10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission File Number: 000-55705

Brighthouse Life Insurance Company of NY

(Exact name of registrant as specified in its charter)

New York	13-3690700
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
285 Madison Avenue, 14th Floor, New York, N.Y.	10017
(Address of principal executive offices)	(Zip Code)

(980) 365-7100

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ    No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes þ    No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨	Accelerated filer  ¨
Non-accelerated filer    þ	Smaller reporting company  ¨
Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ¨    No þ

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class Trading symbol(s) Name of each exchange on which registered

As of May 9, 2019, 200,000 shares of the registrant’s common stock were outstanding, all of which were owned indirectly by Brighthouse Financial, Inc.

REDUCED DISCLOSURE FORMAT

The registrant meets the conditions set forth in General Instruction H(1)(a) and (b) of Form 10-Q and is, therefore, filing this Form 10-Q with the reduced disclosure format.

Table of Contents

		Page
Part I — Financial Information
Item 1.	Financial Statements (at March 31, 2019 (Unaudited) and December 31, 2018 and for the Three Months Ended March 31, 2019 and 2018 (Unaudited)):	2
	Interim Condensed Balance Sheets	2
	Interim Condensed Statements of Operations and Comprehensive Income (Loss)	3
	Interim Condensed Statements of Stockholder’s Equity	4
	Interim Condensed Statements of Cash Flows	5
	Notes to the Interim Condensed Financial Statements (Unaudited):	6
	Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies	6
	Note 2 — Segment Information	8
	Note 3 — Insurance	10
	Note 4 — Investments	11
	Note 5 — Derivatives	18
	Note 6 — Fair Value	24
	Note 7 — Equity	32
	Note 8 — Other Revenues and Other Expenses	33
	Note 9 — Contingencies, Commitments and Guarantees	34
	Note 10 — Related Party Transactions	35
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	38
Item 4.	Controls and Procedures	47
Part II — Other Information
Item 1.	Legal Proceedings	48
Item 1A.	Risk Factors	48
Item 6.	Exhibits	49
Signatures		50

Part I — Financial Information

Item 1. Financial Statements

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Balance Sheets

March 31, 2019 (Unaudited) and December 31, 2018

(In thousands, except share and per share data)

	March 31, 2019		December 31, 2018
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $2,623,070 and $2,469,801, respectively)	$	2,664,864	$	2,433,633
Mortgage loans (net of valuation allowances of $2,006 and $1,937, respectively)	467,193		448,105
Other invested assets, principally at estimated fair value	48,176		35,815
Total investments	3,180,233		2,917,553
Cash and cash equivalents	208,781		120,130
Accrued investment income	22,784		20,605
Premiums, reinsurance and other receivables	574,277		580,480
Deferred policy acquisition costs and value of business acquired	178,073		185,586
Other assets	33,133		37,348
Separate account assets	4,559,757		4,268,423
Total assets	$	8,757,038	$	8,130,125
Liabilities and Stockholder's Equity
Liabilities
Future policy benefits	$	723,951	$	718,599
Policyholder account balances	1,812,080		1,692,498
Other policy-related balances	9,033		9,288
Payables for collateral under derivative transactions	36,791		23,581
Current income tax payable	1,804		1,755
Deferred income tax liability	118,816		107,853
Other liabilities	538,759		471,490
Separate account liabilities	4,559,757		4,268,423
Total liabilities	7,800,991		7,293,487
Contingencies, Commitments and Guarantees (Note 9)
Stockholder's Equity
Common stock, par value $10 per share; 200,000 shares authorized, issued and outstanding	2,000		2,000
Additional paid-in capital	490,931		415,931
Retained earnings (deficit)	432,267		433,778
Accumulated other comprehensive income (loss)	30,849		(15,071		)
Total stockholder's equity	956,047		836,638
Total liabilities and stockholder's equity	$	8,757,038	$	8,130,125

See accompanying notes to the interim condensed financial statements.

2

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Statements of Operations and Comprehensive Income (Loss)

For the Three Months EndedMarch 31, 2019 and 2018 (Unaudited)

(In thousands)

	Three Months Ended   March 31,
	2019			2018
Revenues
Premiums	$	9,032		$	10,293
Universal life and investment-type product policy fees	23,250			25,986
Net investment income	26,493			23,931
Other revenues	(20,323		)	(12,544		)
Net investment gains (losses)	(452		)	(2,355		)
Net derivative gains (losses)	(3,245		)	(44,262		)
Total revenues	34,755			1,049
Expenses
Policyholder benefits and claims	9,459			(1,541		)
Interest credited to policyholder account balances	8,258			9,232
Amortization of deferred policy acquisition costs and value of business acquired	903			(3,323		)
Other expenses	18,890			15,727
Total expenses	37,510			20,095
Income (loss) before provision for income tax	(2,755		)	(19,046		)
Provision for income tax expense (benefit)	(1,244		)	(4,676		)
Net income (loss)	$	(1,511	)	$	(14,370	)
Comprehensive income (loss)	$	44,409		$	(44,660	)

See accompanying notes to the interim condensed financial statements.

3

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Statements of Stockholder’s Equity

For the Three Months EndedMarch 31, 2019 and 2018 (Unaudited)

(In thousands)

	Common Stock		Additional Paid-in Capital		Retained Earnings (Deficit)			Accumulated Other Comprehensive Income (Loss)			Total Stockholder’s Equity
Balance at December 31, 2018	$	2,000	$	415,931	$	433,778		$	(15,071	)	$	836,638
Net income (loss)					(1,511		)				(1,511		)
Capital contribution			75,000								75,000
Other comprehensive income (loss), net of income tax								45,920			45,920
Balance at March 31, 2019	$	2,000	$	490,931	$	432,267		$	30,849		$	956,047
	Common Stock		Additional Paid-in Capital		Retained Earnings (Deficit)			Accumulated Other Comprehensive Income (Loss)			Total Stockholder’s Equity
Balance at December 31, 2017	$	2,000	$	415,931	$	395,928		$	29,628		$	843,487
Net income (loss)					(14,370		)				(14,370		)
Other comprehensive income (loss), net of income tax								(30,290		)	(30,290		)
Balance at March 31, 2018	$	2,000	$	415,931	$	381,558		$	(662	)	$	798,827

See accompanying notes to the interim condensed financial statements.

4

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Interim Condensed Statements of Cash Flows

For the Three Months EndedMarch 31, 2019 and 2018 (Unaudited)

(In thousands)

	Three Months Ended   March 31,
	2019			2018
Net cash provided by (used in) operating activities	$	3,673		$	23,949
Cash flows from investing activities
Sales, maturities and repayments of:
Fixed maturity securities	70,442			77,753
Mortgage loans	1,618			2,399
Purchases of:
Fixed maturity securities	(157,155		)	(141,218		)
Mortgage loans	(22,322		)	(14,445		)
Cash received in connection with freestanding derivatives	23,716			212
Cash paid in connection with freestanding derivatives	(2,827		)	(29,892		)
Net change in short-term investments	3			(7,978		)
Net change in other invested assets	6,943			425
Net cash provided by (used in) investing activities	(79,582		)	(112,744		)
Cash flows from financing activities
Policyholder account balances:
Deposits	131,693			117,755
Withdrawals	(55,343		)	(33,962		)
Net change in payables for collateral under derivative transactions	13,210			10,830
Capital contribution	75,000			—
Net cash provided by (used in) financing activities	164,560			94,623
Change in cash, cash equivalents and restricted cash	88,651			5,828
Cash, cash equivalents and restricted cash, beginning of period	120,130			86,154
Cash, cash equivalents and restricted cash, end of period	$	208,781		$	91,982
Supplemental disclosures of cash flow information
Net cash paid (received) for:
Income tax	$	—		$	4

See accompanying notes to the interim condensed financial statements.

5

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“BHNY” and the “Company” refer to Brighthouse Life Insurance Company of NY, a New York domiciled life insurance company. Brighthouse Life Insurance Company of NY is a wholly-owned subsidiary of Brighthouse Life Insurance Company, which is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (“BHF” together with its subsidiaries and affiliates, “Brighthouse Financial”). The Company is licensed to transact business in the state of New York.

BHNY markets and/or administers traditional life, universal life, variable annuity and fixed annuity products to individuals. The Company is organized into two segments: Annuities; and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

In 2016, MetLife, Inc. (together with its subsidiaries and affiliates, “MetLife”) announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). In connection with the Separation,80.8% of MetLife, Inc.’s interest in BHF was distributed to holders of MetLife, Inc.’s common stock. On June 14, 2018, MetLife, Inc. divested its remaining shares of BHF common stock (the “MetLife Divestiture”). As a result, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties subsequent to the MetLife Divestiture.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Reclassifications

Certain amounts in the prior year periods’ interim condensed financial statements and related footnotes thereto have been reclassified to conform with the 2019 presentation as may be discussed throughout the Notes to the Interim Condensed Financial Statements.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

The accompanying interim condensed financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2018 balance sheet data was derived from audited financial statements included in BHNY’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed financial statements should be read in conjunction with the financial statements of the Company included in the 2018 Annual Report.

Adoption of New Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s financial statements. There were no ASUs adopted during the first quarter of 2019 which had a material impact on the Company’s financial statements.

6

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

ASUs issued but not yet adopted as of March 31, 2019 are summarized in the table below.

Standard	Description	Effective Date	Impact on Financial Statements
ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts	The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (1) require all guarantees that qualify as market risk benefits to be measured at fair value, (2) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (3) modify the methods of amortization for deferred acquisition costs, and (4) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances.	January 1, 2021 using a modified retrospective method for the new market risk benefit guidance and prospective methods for the increased frequency of updating assumptions, the new discount rate requirements and deferred policy acquisition costs (“DAC”) amortization changes. Early adoption is permitted.	The Company is in the early stages of evaluating the new guidance and therefore is unable to estimate the impact to its financial statements. The most significant impact will be the measurement of liabilities for variable annuity guarantees.
ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments	The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than- temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses.	January 1, 2020 using the modified retrospective method (with early adoption permitted beginning January 1, 2019)	The Company is currently evaluating the impact of this guidance on its financial statements, with the most significant impact expected to be earlier recognition of credit losses on mortgage loan investments.

7

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information

The Company is organized into two segments: Annuities and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

Annuities

The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.

Life

The Life segment consists of insurance products and services, including term, whole and universal life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.

Corporate & Other

Corporate & Other contains the excess capital not allocated to the segments and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts and a portion of MetLife’s former U.S. insurance business sold direct to consumers, which is no longer being offered for new sales.

Financial Measures and Segment Accounting Policies

Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Adjusted earnings should not be viewed as a substitute for net income (loss).

Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends.

The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and

• Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).

The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:

• Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and

• Amortization of DAC and value of business acquired related to: (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.

The tax impact of the adjustments mentioned above is calculated net of the statutory tax rate, which could differ from the Company’s effective tax rate.

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months ended March 31, 2019 and 2018 and at March 31, 2019 and December 31, 2018. The segment accounting policies are the same as those used to prepare the Company’s condensed financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below.

8

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information (continued)

Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital. Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets.

	Operating Results
Three Months Ended March 31, 2019	Annuities			Life			Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	(4,979	)	$	(4,256	)	$	(553	)	$	(9,788	)
Provision for income tax expense (benefit)	(1,468		)	(894		)	(359		)	(2,721		)
Adjusted earnings	$	(3,511	)	$	(3,362	)	$	(194	)	(7,067		)
Adjustments for:
Net investment gains (losses)										(452		)
Net derivative gains (losses)										(3,245		)
Other adjustments to net income										10,730
Provision for income tax (expense) benefit										(1,477		)
Net income (loss)										$	(1,511	)
Interest revenue	$	17,772		$	8,304		$	509

	Operating Results
Three Months Ended March 31, 2018	Annuities		Life		Corporate & Other		Total
	(In thousands)
Pre-tax adjusted earnings	$	5,430	$	8,014	$	2,262	$	15,706
Provision for income tax expense (benefit)	657		1,683		281		2,621
Adjusted earnings	$	4,773	$	6,331	$	1,981	13,085
Adjustments for:
Net investment gains (losses)							(2,355		)
Net derivative gains (losses)							(44,262		)
Other adjustments to net income							11,865
Provision for income tax (expense) benefit							7,297
Net income (loss)							$	(14,370	)
Interest revenue	$	14,803	$	8,839	$	371

9

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

2. Segment Information (continued)

The following table presents total revenues with respect to the Company’s segments, as well as Corporate & Other:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Annuities	$	21,887		$	27,638
Life	12,647			15,696
Corporate & Other	670			1,024
Adjustments	(449		)	(43,309		)
Total	$	34,755		$	1,049

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	March 31, 2019		December 31, 2018
	(In thousands)
Annuities	$	7,539,919	$	7,034,394
Life	1,124,314		1,083,641
Corporate & Other	92,805		12,090
Total	$	8,757,038	$	8,130,125

3. Insurance

Guarantees

As discussed in Notes1and3of the Notes to the Financial Statements included in the 2018 Annual Report, the Company issues variable annuity contracts with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”), the non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”) and certain portions of GMIBs that do not require the policyholder to annuitize are accounted for as embedded derivatives in policyholder account balances and are further discussed inNote 5.

Information regarding the Company’s guarantee exposure was as follows at:

	March 31, 2019						December 31, 2018
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in thousands)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	4,564,444		$	3,703,604		$	4,274,326		$	3,483,668
Separate account value	$	4,557,551		$	3,702,932		$	4,266,520		$	3,482,829
Net amount at risk	$	22,344	(4)	$	211,888	(5)	$	193,102	(4)	$	274,632	(5)
Average attained age of contract holders	68 years			67 years			67 years			67 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, thenet amount at riskpresented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. SeeNote 5of the Notes to the Financial Statementsincluded in the2018Annual Report for a discussion ofguaranteed minimum benefitswhich have been reinsured.

(3) Includes the contract holder’s investments in the general account and separate account, if applicable.

10

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

3. Insurance (continued)

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.

4. Investments

See Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for a description of the Company’s accounting policies for investments and Note 6 for information about the fair value hierarchy for investments and the related valuation methodologies.

Fixed Maturity Securities Available-for-sale (“AFS”)

Fixed Maturity Securities AFS by Sector

The following table presents the fixed maturity securities AFS by sector at:

	March 31, 2019										December 31, 2018
	Amortized Cost		Gross Unrealized						Estimated Fair Value		Amortized Cost		Gross Unrealized						Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses						Gains		Temporary Losses		OTTI Losses
	(In thousands)
Fixed maturity securities: (1)
U.S. corporate	$	916,754	$	21,416	$	7,539	$	—	$	930,631	$	890,676	$	5,402	$	23,034	$	—	$	873,044
U.S. government and agency	504,101		15,524		4,269		—		515,356		511,255		9,961		13,697		—		507,519
Foreign corporate	374,509		6,641		7,194		—		373,956		368,149		1,473		17,258		—		352,364
CMBS	336,322		7,335		1,216		—		342,441		325,491		1,481		4,121		—		322,851
RMBS	315,454		6,879		1,973		—		320,360		200,827		4,643		2,882		—		202,588
ABS	83,618		262		489		—		83,391		79,806		158		1,133		—		78,831
State and political subdivision	65,995		6,168		70		—		72,093		66,131		4,777		1,083		—		69,825
Foreign government	26,317		692		373		—		26,636		27,466		140		995		—		26,611
Total fixed maturity securities	$	2,623,070	$	64,917	$	23,123	$	—	$	2,664,864	$	2,469,801	$	28,035	$	64,203	$	—	$	2,433,633

__________________

(1) Redeemable preferred stock is reported within foreign corporate fixed maturity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”).

The Company did not hold non-income producing fixed maturity securities at both March 31, 2019 and December 31, 2018.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at March 31, 2019:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In thousands)
Amortized cost	$	56,296	$	342,812	$	898,149	$	590,419	$	735,394	$	2,623,070
Estimated fair value	$	56,866	$	344,578	$	906,709	$	610,519	$	746,192	$	2,664,864

11

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	March 31, 2019								December 31, 2018
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in thousands)
Fixed maturity securities:
U.S. corporate	$	54,218	$	1,415	$	213,094	$	6,124	$	483,424	$	15,849	$	131,812	$	7,185
U.S. government and agency	—		—		264,905		4,269		102,447		1,925		296,265		11,772
Foreign corporate	68,008		3,251		102,547		3,943		194,924		10,156		72,803		7,102
CMBS	8,975		58		67,525		1,158		119,412		1,909		44,775		2,212
RMBS	72,806		130		46,591		1,843		57,510		1,746		28,573		1,136
ABS	39,489		389		11,104		100		51,028		985		11,699		148
State and political subdivision	6,175		25		7,815		45		18,260		744		13,999		339
Foreign government	10,645		373		—		—		7,435		716		6,782		279
Total fixed maturity securities	$	260,316	$	5,641	$	713,581	$	17,482	$	1,034,440	$	34,030	$	606,708	$	30,173
Total number of securities in an unrealized loss position	108				181				364				146

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

Evaluation and Measurement Methodologies

Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.

12

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

For securities in an unrealized loss position, an OTTI is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in other comprehensive income (“OCI”).

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at March 31, 2019.

Gross unrealized losses on fixed maturity securities decreased$41.1 million during the three months ended March 31, 2019 to $23.1 million. The decrease in gross unrealized losses for the three months ended March 31, 2019 was primarily attributable to decreasing longer-term interest rates and narrowing credit spreads.

At March 31, 2019, $940 thousand of the total $23.1 million of gross unrealized losses were from one fixed maturity security with an unrealized loss position of 20% or more of amortized cost for six months or greater.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	March 31, 2019					December 31, 2018
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in thousands)
Mortgage loans:
Commercial	$	319,650		68.4	%	$	310,681		69.3	%
Agricultural	149,549			32.0		139,361			31.1
Subtotal	469,199			100.4		450,042			100.4
Valuation allowances (1)	(2,006		)	(0.4	)	(1,937		)	(0.4	)
Total mortgage loans, net	$	467,193		100.0	%	$	448,105		100.0	%

__________________

(1) The valuation allowances were primarily from collective evaluation (non-specific loan related).

Information on commercial and agricultural mortgage loans is presented in the tables below.

13

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Valuation Allowance Methodology

Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in thousands)
March 31, 2019
Loan-to-value ratios:
Less than 65%	$	277,674	$	5,000	$	13,448	$	296,122	92.7	%
65% to 75%	19,240		—		—		19,240		6.0
76% to 80%	4,288		—		—		4,288		1.3
Total	$	301,202	$	5,000	$	13,448	$	319,650	100.0	%
December 31, 2018
Loan-to-value ratios:
Less than 65%	$	273,681	$	5,000	$	13,447	$	292,128	94.0	%
65% to 75%	14,257		—		—		14,257		4.6
76% to 80%	4,296		—		—		4,296		1.4
Total	$	292,234	$	5,000	$	13,447	$	310,681	100.0	%

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at: 

	March 31, 2019				December 31, 2018
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in thousands)
Loan-to-value ratios:
Less than 65%	$	141,731	94.8	%	$	133,884	96.1	%
65% to 75%	7,818		5.2		5,477		3.9
Total	$	149,549	100.0	%	$	139,361	100.0	%

14

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Past Due, Nonaccrual and Modified Mortgage Loans

The Company has a high quality, well performing mortgage loan portfolio, with all mortgage loans classified as performing at both March 31, 2019 and December 31, 2018. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans — 60 days and agricultural mortgage loans — 90 days. The Company had no commercial or agricultural mortgage loans past due and no commercial or agricultural mortgage loans in nonaccrual status at either March 31, 2019 or December 31, 2018. During both the three months ended March 31, 2019 and 2018, the Company did not have any mortgage loans modified in a troubled debt restructuring.

Cash Equivalents

The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $0 and $89.9 million at March 31, 2019 and December 31, 2018, respectively.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC, deferred sales inducements (“DSI”) and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (“AOCI”).

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	March 31, 2019			December 31, 2018
	(In thousands)
Fixed maturity securities	$	41,793		$	(36,166	)
Derivatives	4,756			5,791
Subtotal	46,549			(30,375		)
Amounts allocated from:
DAC and DSI	(7,500		)	11,299
Deferred income tax benefit (expense)	(8,200		)	4,005
Net unrealized investment gains (losses)	$	30,849		$	(15,071	)

The changes in net unrealized investment gains (losses) were as follows:

	Three Months Ended   March 31, 2019
	(In thousands)
Balance, December 31, 2018	$	(15,071	)
Unrealized investment gains (losses) during the period	76,924
Unrealized investment gains (losses) relating to:
DAC and DSI	(18,799		)
Deferred income tax benefit (expense)	(12,205		)
Balance, March 31, 2019	$	30,849
Change in net unrealized investment gains (losses)	$	45,920

Concentrations of Credit Risk

There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both March 31, 2019 and December 31, 2018.

15

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Invested Assets on Deposit and Pledged as Collateral

Invested assets on deposit and pledged as collateral are presented below at estimated fair value:

	March 31, 2019		December 31, 2018
	(In thousands)
Invested assets on deposit (regulatory deposits)	$	1,530	$	1,482
Invested assets pledged as collateral (1)	8,652		158
Total invested assets on deposit and pledged as collateral (2)	$	10,182	$	1,640

__________________

(1) The Company has pledged invested assets in connection with derivative transactions (see Note 5).

(2) The Company held no restricted cash at both March 31, 2019 and December 31, 2018.

Variable Interest Entities

The Company has invested in legal entities that are variable interest entities (“VIEs”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and the obligation to absorb losses, or the right to receive benefits that could potentially be significant to the VIE.

There were no material VIEs for which the Company has concluded that it is the primary beneficiary at March 31, 2019 or December 31, 2018.

The Company’s investments in unconsolidated VIEs are described below.

Fixed Maturity Securities

The Company invests in U.S. corporate bonds, foreign corporate bonds, and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities AFS” for information on these securities.

	March 31, 2019				December 31, 2018
	Carrying Amount		Maximum Exposure to Loss		Carrying Amount		Maximum Exposure to Loss
	(In thousands)
Fixed maturity securities	$	489,002	$	480,919	$	409,699	$	409,699

16

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Net Investment Income

The components of net investment income were as follows:

	Three Months Ended   March 31,
	2019		2018
	(In thousands)
Investment income:
Fixed maturity securities	$	22,913	$	20,365
Mortgage loans	3,899		4,191
Cash, cash equivalents and short-term investments	387		158
Other	350		96
Subtotal	27,549		24,810
Less: Investment expenses	1,056		879
Net investment income	$	26,493	$	23,931

See “— Related Party Investment Transactions” for discussion of related party investment expenses.

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Fixed maturity securities	$	(468	)	$	(2,839	)
Mortgage loans	(69		)	(82		)
Other	85			566
Total net investment gains (losses)	$	(452	)	$	(2,355	)

Gains (losses) from foreign currency transactions included within net investment gains (losses) were $10 thousand and $414 thousand for the three months ended March 31, 2019 and 2018, respectively.

Sales or Disposals of Fixed Maturity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as shown in the table below.

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Proceeds	$	55,477		$	53,561
Gross investment gains	$	150		$	15
Gross investment losses	(618		)	(2,854		)
Net investment gains (losses)	$	(468	)	$	(2,839	)

17

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

4. Investments (continued)

Related Party Investment Transactions

The Company receives investment administrative services from MetLife Investment Advisors, LLC, which was considered a related party investment manager until the completion of the MetLife Divestiture. The related investment administrative service charges were$0and$766 thousandfor thethree monthsendedMarch 31, 2019and 2018, respectively. All of the charges reported as related party activity in 2018 occurred prior to the MetLife Divestiture. See Note1regarding the MetLife Divestiture.

5. Derivatives

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).

Hedge Accounting

The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable and index-linked annuities and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated and measured at fair value, separately from the host contract. The Company bifurcates embedded derivatives when a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument, the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and the underlying contract is not already measured at estimated fair value with changes recorded in earnings.

18

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

See “— Future Policy Benefit Liabilities and Policyholder Account Balances”, “— Index-Linked Annuities” and “— Reinsurance” in the Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps and option contracts.

Interest Rate Derivatives

The Company purchases interest rate caps to protect against rises in long-term interest rates. The Company utilizes interest rate caps in nonqualifying hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets denominated in foreign currencies.

In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and nonqualifying hedging relationships.

Equity Derivatives

The Company uses equity index options to reduce exposure to rising equity markets associated with fixed annuities with equity indexed returns. The Company utilizes equity index options in nonqualifying hedging relationships.

Primary Risks Managed by Derivatives

The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:

		March 31, 2019						December 31, 2018
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In thousands)
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency swaps	Foreign currency exchange rate	$	83,513	$	4,563	$	130	$	82,704	$	5,649	$	187
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate caps	Interest rate	800,000		4,772		—		800,000		9,284		—
Foreign currency swaps	Foreign currency exchange rate	17,892		3,191		96		28,133		3,395		144
Equity index options	Equity market	2,307,473		35,487		9,969		2,154,321		10,389		96
Total non-designated or nonqualifying derivatives		3,125,365		43,450		10,065		2,982,454		23,068		240
Total		$	3,208,878	$	48,013	$	10,195	$	3,065,158	$	28,717	$	427

19

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

The following tables present the amount and location of gains (losses) recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):

	Net Derivative Gains (Losses) Recognized for Derivatives (1), (4)			Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)		Net Investment Income (5)		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Three Months Ended March 31, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	—		$	—	$	270	$	(1,035	)
Total cash flow hedges	—			—		270		(1,035		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,512		)	—		—		—
Foreign currency exchange rate derivatives	(36		)	88		—		—
Equity derivatives	36,116			—		—		—
Embedded derivatives	(34,901		)	—		—		—
Total non-qualifying hedges	(3,333		)	88		—		—
Total	$	(3,333	)	$	88	$	270	$	(1,035	)
Three Months Ended March 31, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	6		$	—	$	186	$	(2,674	)
Total cash flow hedges	6			—		186		(2,674		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,002		)	—		—		—
Foreign currency exchange rate derivatives	(972		)	152		—		—
Equity derivatives	(8,736		)	—		—		—
Embedded derivatives	(30,710		)	—		—		—
Total non-qualifying hedges	(44,420		)	152		—		—
Total	$	(44,414	)	$	152	$	186	$	(2,674	)

______________

(1) Includes gains (losses) reclassified from AOCI primarily for terminated cash flow hedges.

(2) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships.

(3) All components of each derivative's gain or loss were included in the assessment of hedge effectiveness.

(4) Total net derivative gains (losses) were ($3.2) million and ($44.3) million for the three months ended March 31, 2019 and 2018 respectively.

(5) Total net investment income was ($452) thousand and ($2.4) million for the three months ended March 31, 2019 and 2018 respectively.

At March 31, 2019 and December 31, 2018, the balance in AOCI associated with foreign currency swaps designated and qualifying as cash flow hedges was $4.8 million and $5.8 million, respectively.

20

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

Counterparty Credit Risk

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by International Swaps and Derivatives Association, Inc. (“ISDA”) Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

See Note 6 for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	March 31, 2019						December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In thousands)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	48,331		$	10,160		$	29,006		$	411
Total gross estimated fair value of derivatives (1)	48,331			10,160			29,006			411
Amounts offset on the balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the balance sheets (1)	48,331			10,160			29,006			411
Gross amounts not offset on the balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(3,825		)	(3,825		)	(365		)	(365		)
Cash collateral: (3)
OTC-bilateral	(34,235		)	—			(23,197		)	—
Securities collateral: (4)
OTC-bilateral	(2,875		)	(6,335		)	(2,212		)	(46		)
Net amount after application of master netting agreements and collateral	$	7,396		$	—		$	3,232		$	—

______________

(1) At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $318 thousand and $289 thousand, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($35) thousand and ($16) thousand, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received is included in cash and cash equivalents or in short-term investments, and the obligation to return it is included in payables for collateral transactions on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $2.6 million and $384 thousand, respectively, and did not provide any excess cash collateral, which is not included in the table above due to the foregoing limitation.

21

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

(4) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but atMarch 31, 2019,noneof the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. AtMarch 31, 2019andDecember 31, 2018, the Company received excess securities collateral with an estimated fair value of$3.9 millionand$78 thousand, respectively, and provided excess securities collateral with an estimated fair value of$2.3 millionand$112 thousand, respectively, for its OTC-bilateral derivatives.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. In addition, the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’sInvestors ServiceandStandard & Poor’s Global Ratings500 Index. If a party’s financial strength or credit ratings were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

At March 31, 2019 and December 31, 2018, the Company held OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements with an estimated fair value of $6.3 million and $46 thousand, respectively. At March 31, 2019 and December 31, 2018, the Company provided collateral with an estimated fair value of $8.7 million and $158 thousand, respectively. The Company’s collateral agreements require both parties to be fully collateralized, as such, the Company would not be required to post additional collateral as a result of a downgrade in its financial strength rating.

Embedded Derivatives

The Company issues certain insurance contracts that contain embedded derivatives that are required to be separated from their host contracts and measured at fair value. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; related party ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; and fixed annuities with equity-indexed returns.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	March 31, 2019			December 31, 2018
		(In thousands)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	295,107		$	298,112
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	(33,520	)	$	(18,811	)
Fixed annuities with equity indexed returns	Policyholder account balances	66,887			5,617
Embedded derivatives within liability host contracts		$	33,367		$	(13,194	)

22

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

5. Derivatives (continued)

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net derivative gains (losses) (1), (2)	$	(34,901	)	$	(30,710	)

______________

(1) The valuation of direct guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($3.4) millionand($1.1) millionfor thethree months endedMarch 31, 2019, and2018, respectively. In addition, the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were$19.8 millionand($600) thousandfor thethree months endedMarch 31, 2019and2018, respectively.

(2) See Note 10 for discussion of related party net derivative gains (losses).

23

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, are presented below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy.

	March 31, 2019
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	926,863	$	3,768	$	930,631
U.S. government and agency	391,637		123,719		—		515,356
Foreign corporate	—		363,999		9,957		373,956
CMBS	—		337,733		4,708		342,441
RMBS	—		320,360		—		320,360
ABS	—		77,922		5,469		83,391
State and political subdivision	—		72,093		—		72,093
Foreign government	—		26,636		—		26,636
Total fixed maturity securities	391,637		2,249,325		23,902		2,664,864
Derivative assets: (1)
Interest rate	—		4,772		—		4,772
Foreign currency exchange rate	—		7,754		—		7,754
Equity market	—		35,487		—		35,487
Total derivative assets	—		48,013		—		48,013
Embedded derivatives within asset host contracts (2)	—		—		295,107		295,107
Separate account assets	—		4,559,757		—		4,559,757
Total assets	$	391,637	$	6,857,095	$	319,009	$	7,567,741
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	226	$	—	$	226
Equity market	—		9,969		—		9,969
Total derivative liabilities	—		10,195		—		10,195
Embedded derivatives within liability host contracts (2)	—		—		33,367		33,367
Total liabilities	$	—	$	10,195	$	33,367	$	43,562

24

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

	December 31, 2018
	Fair Value Hierarchy
	Level 1		Level 2		Level 3			Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	869,498	$	3,546		$	873,044
U.S. government and agency	389,491		118,028		—			507,519
Foreign corporate	—		342,600		9,764			352,364
CMBS	—		318,120		4,731			322,851
RMBS	—		202,588		—			202,588
ABS	—		78,831		—			78,831
State and political subdivision	—		69,825		—			69,825
Foreign government	—		26,611		—			26,611
Total fixed maturity securities	389,491		2,026,101		18,041			2,433,633
Derivative assets: (1)
Interest rate	—		9,284		—			9,284
Foreign currency exchange rate	—		8,572		472			9,044
Equity market	—		10,389		—			10,389
Total derivative assets	—		28,245		472			28,717
Embedded derivatives within asset host contracts (2)	—		—		298,112			298,112
Separate account assets	—		4,268,423		—			4,268,423
Total assets	$	389,491	$	6,322,769	$	316,625		$	7,028,885
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	331	$	—		$	331
Equity market	—		96		—			96
Total derivative liabilities	—		427		—			427
Embedded derivatives within liability host contracts (2)	—		—		(13,194		)	(13,194		)
Total liabilities	$	—	$	427	$	(13,194	)	$	(12,767	)

______________

(1) Derivative assets are presented within other invested assets on the balance sheets and derivative liabilities are presented within other liabilities on the balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the balance sheets.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets.

Valuation Controls and Procedures

The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards.

25

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

The fair value of financial assets and financial liabilities is based on quoted market prices, where available. The Company assesses whether prices received represent a reasonable estimate of fair value through controls designed to ensure valuations represent an exit price. Valuation service providers perform several controls, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments.

Valuation service providers also apply a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, valuation service providers will use the last available price.

The Company reviews outputs of the valuation service providers’ controls and performs additional controls, including certain monthly controls, which include but are not limited to, performing balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the three months ended March 31, 2019.

Determination of Fair Value

Fixed Maturity Securities

The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below.

U.S. corporate and foreign corporate securities:Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues.

U.S. government and agency, state and political subdivision and foreign government securities:Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker dealer quotes, and comparable securities that are actively traded.

Structured Securities:Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance.

26

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

Derivatives

The fair values for OTC-bilateral derivatives and OTC-cleared derivatives classified as Level 2 assets or liabilities, fair values are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs.

The significant inputs to the pricing models for most OTC-bilateral derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income. 

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Embedded Derivatives

Embedded derivatives principally include certain direct variable annuity guarantees and certain affiliated ceded reinsurance agreements related to such variable annuity guarantees. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the balance sheets.

The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

27

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees.

Transfers Into or Out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					March 31, 2019			December 31, 2018			Impact of Increase in Input on Estimated Fair Value
	Valuation Techniques		Significant Unobservable Inputs		Range			Range
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates	0.02%	-	11.31%	0.02%	-	11%	Decrease (1)
			•	Lapse rates	0.25%	-	16%	0.25%	-	16%	Decrease (2)
			•	Utilization rates	0%	-	25%	0%	-	25%	Increase (3)
			•	Withdrawal rates	0.25%	-	10%	0.25%	-	10%	(4)
			•	Long-term equity volatilities	16.50%	-	22%	16.50%	-	22%	Increase (5)
			•	Nonperformance risk spread	1.31%	-	2.45%	1.91%	-	2.66%	Decrease (6)

______________

(1) Mortality rates vary by age and by demographic characteristics such as gender. Range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.

(2) Range reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.

(3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder.

28

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

(4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value.

29

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			Net Derivatives (2)			Net Embedded Derivatives (3)
	(In thousands)
Three Months Ended March 31, 2019
Balance, beginning of period	$	13,310		$	4,731		$	472		$	311,306
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	2			(32		)	—			(34,901		)
Total realized/unrealized gains (losses) included in AOCI	403			78			—			—
Purchases (6)	—			—			—			—
Sales (6)	(48		)	(29		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(14,665		)
Transfers into Level 3 (7)	263			5,429			—			—
Transfers out of Level 3 (7)	(205		)	—			(472		)	—
Balance, end of period	$	13,725		$	10,177		$	—		$	261,740
Three Months Ended March 31, 2018
Balance, beginning of period	$	95,950		$	19,557		$	—		$	347,633
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	1			109			—			(30,710		)
Total realized/unrealized gains (losses) included in AOCI	(772		)	119			—			—
Purchases (6)	783			1,955			—			—
Sales (6)	(716		)	(403		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(5,912		)
Transfers into Level 3 (7)	—			—			—			—
Transfers out of Level 3 (7)	(3,166		)	—			—			—
Balance, end of period	$	92,080		$	21,337		$	—		$	311,011
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2019 (8)	$	4		$	(32	)	$	—		$	13,080
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2018 (8)	$	1		$	109		$	—		$	(33,063	)

______________

(1) Comprised of U.S. and foreign corporate securities.

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

(5) Interest accruals, as well as cash interest coupons received, are excluded from the rollforward.

30

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

6. Fair Value (continued)

(6) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(7) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(8) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under derivative transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	March 31, 2019
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	467,193	$	—	$	—	$	472,882	$	472,882
Premiums, reinsurance and other receivables	$	18,415	$	—	$	4,055	$	13,021	$	17,076
Liabilities
Policyholder account balances	$	1,014,394	$	—	$	—	$	938,827	$	938,827
Other liabilities	$	81,790	$	—	$	81,790	$	—	$	81,790

	December 31, 2018
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	448,105	$	—	$	—	$	447,510	$	447,510
Premiums, reinsurance and other receivables	$	20,001	$	—	$	2,314	$	15,512	$	17,826
Liabilities
Policyholder account balances	$	1,056,419	$	—	$	—	$	949,916	$	949,916
Other liabilities	$	10,399	$	—	$	10,399	$	—	$	10,399

31

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

7. Equity

Capital Transactions

During the three months ended March 31, 2019, the Company received a cash capital contribution of $75 million from Brighthouse Life Insurance Company.

Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI was as follows:

	Three Months Ended   March 31, 2019
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2018	$	(20,503	)	$	5,432		$	(15,071	)
OCI before reclassifications	58,689			(1,035		)	57,654
Deferred income tax benefit (expense)	(12,325		)	217			(12,108		)
AOCI before reclassifications, net of income tax	25,861			4,614			30,475
Amounts reclassified from AOCI	471			—			471
Deferred income tax benefit (expense)	(97		)	—			(97		)
Amounts reclassified from AOCI, net of income tax	374			—			374
Balance, March 31, 2019	$	26,235		$	4,614		$	30,849

	Three Months Ended   March 31, 2018
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2017	$	29,323		$	305		$	29,628
OCI before reclassifications	(38,499		)	(2,674		)	(41,173		)
Deferred income tax benefit (expense)	8,083			562			8,645
AOCI before reclassifications, net of income tax	(1,093		)	(1,807		)	(2,900		)
Amounts reclassified from AOCI	2,839			(6		)	2,833
Deferred income tax benefit (expense)	(596		)	1			(595		)
Amounts reclassified from AOCI, net of income tax	2,243			(5		)	2,238
Balance, March 31, 2018	$	1,150		$	(1,812	)	$	(662	)

______________

(1) See Note 4 for information on offsets to investments related to DAC and DSI.

32

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

7. Equity (continued)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI						Statements of Operations and Comprehensive Income (Loss) Locations
	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	(465	)	$	(2,839	)	Net investment gains (losses)
Net unrealized investment gains (losses)	(6		)	—			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(471		)	(2,839		)
Income tax (expense) benefit	97			596
Net unrealized investment gains (losses), net of income tax	(374		)	(2,243		)
Unrealized gains (losses) on derivatives - cash flow hedges:
Foreign currency swaps	—			6			Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	—			6
Income tax (expense) benefit	—			(1		)
Gains (losses) on cash flow hedges, net of income tax	—			5
Total reclassifications, net of income tax	$	(374	)	$	(2,238	)

8. Other Revenues and Other Expenses

Other Revenues

The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees.

To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees.

Other revenues consisted primarily of 12b-1 fees of $3.1 million and $3.5 million for the three months ended March 31, 2019 and 2018, respectively, of which all were reported in the Annuities segment.

33

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

8. Other Revenues and Other Expenses (continued)

Other Expenses

Information on other expenses was as follows:

	Three Months Ended   March 31,
	2019		2018
	(In thousands)
Compensation	$	4,667	$	3,510
Contracted services and other labor costs	2,596		1,837
Transition services agreements	3,784		2,947
Establishment costs	1,482		—
Premium and other taxes, licenses and fees	704		1,043
Volume related costs, excluding compensation, net of DAC capitalization	3,998		5,264
Other	1,659		1,126
Total other expenses	$	18,890	$	15,727

Related Party Expenses

See Note 10 for a discussion of related party expenses included in the table above.

9. Contingencies, Commitments and Guarantees

Contingencies

Litigation

Sales Practices Claims

Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its financial statements for all probable and reasonably estimable losses for sales practices matters.

Summary

Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s net income or cash flows in particular quarterly or annual periods.

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $21.8 million and $7.6 million at March 31, 2019 and December 31, 2018, respectively.

34

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

9. Contingencies, Commitments and Guarantees (continued)

Commitments to Fund Private Corporate Bond Investments

The Company commits to lend funds under private corporate bond investments. The amounts of these unfunded commitments were$3.5 millionand$11.4 millionatMarch 31, 2019andDecember 31, 2018, respectively.

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company had no liability for indemnities, guarantees and commitments at both March 31, 2019 and December 31, 2018.

10. Related Party Transactions

The Company has various existing arrangements with its Brighthouse affiliates and had previous arrangements with MetLife for services necessary to conduct its activities. Certain of the MetLife services have continued, however, MetLife was no longer considered a related party upon the completion of the MetLife Divestiture on June 14, 2018 (see Note 1). The Company has related party investment and equity transactions (see Notes 4 and 7). Other material arrangements between the Company and its related parties not disclosed elsewhere are as follows:

Reinsurance Agreements

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

35

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

10. Related Party Transactions (continued)

Information regarding the significant effects of related party reinsurance included on the interim condensed statements of operations and comprehensive income (loss) was as follows:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Premiums
Reinsurance ceded	$	(10,210	)	$	(8,112	)
Universal life and investment-type product policy fees
Reinsurance ceded	$	(803	)	$	(1,043	)
Other revenues
Reinsurance ceded	$	(23,508	)	$	(15,936	)
Policyholder benefits and claims
Reinsurance ceded	$	(8,213	)	$	(24,732	)

Information regarding the significant effects of ceded related party reinsurance included on the interim condensed balance sheets was as follows at:

	March 31, 2019		December 31, 2018
	(In thousands)
Assets
Premiums, reinsurance and other receivables	$	522,891	$	534,487
Liabilities
Other liabilities	$	420,568	$	429,656

The Company cedes risks to Brighthouse Life Insurance Company related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in the estimated fair value are included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were $295.1 million and $298.1 million at March 31, 2019 and December 31, 2018, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($3.5) million and ($45.8) million for the three months ended March 31, 2019 and 2018, respectively.

Shared Services and Overhead Allocations

Brighthouse affiliates currently provide and previously MetLife provided the Company certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. Costs incurred under these arrangements with Brighthouse affiliates, as well as with MetLife prior to the MetLife Divestiture, were $15.1 million and $9.7 million for the three months ended March 31, 2019 and 2018, respectively, and were recorded in other expenses. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $2.9 million and $3.2 million for the three months ended March 31, 2019 and 2018, respectively.

The Company had net receivables (payables) from/to affiliates, related to the items discussed above, of ($941) thousand and $622 thousand at March 31, 2019 and December 31, 2018, respectively.

Brighthouse affiliates incur costs related to the establishment of services and infrastructure to replace those previously provided by MetLife. The Company is charged a fee to reflect the value of the available infrastructure and services provided by these costs. While management believes the method used to allocate expenses under this arrangement is reasonable, the allocated expenses may not be indicative of those of a stand-alone entity. If expenses were allocated to the Company under this arrangement as incurred by Brighthouse affiliates, the Company would have incurred additional expenses of ($260) thousand for the three months ended March 31, 2019. The Company would have incurred no additional expenses under this arrangement for the three months ended March 31, 2018.

36

Brighthouse Life Insurance Company of NY

(An Indirect Wholly-Owned Subsidiary of Brighthouse Financial, Inc.)

Notes to the Interim Condensed Financial Statements (Unaudited) (continued)

10. Related Party Transactions (continued)

Broker-Dealer Transactions

The related party expense for the Company was commissions collected on the sale of variable products by the Company and passed through to the broker-dealer. The related party revenue for the Company was fee income from trusts and mutual funds whose shares serve as investment options of policyholders of the Company. Fee income received from affiliates related to these transactions and recorded in other revenues was$2.8 millionand$3.2 millionfor thethree monthsendedMarch 31, 2019and2018, respectively. Commission expenses incurred from affiliates related to these transactions and recorded in other expenses was$14.7 millionand$13.1 millionfor thethree monthsendedMarch 31, 2019and2018, respectively. The Company also had related party fee income receivables of$993 thousandand$951 thousandatMarch 31, 2019andDecember 31, 2018, respectively.

37

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Page
Introduction	39
Overview	39
Summary of Critical Accounting Estimates	39
Non-GAAP and Other Financial Disclosures	40
Results of Operations	42
Note Regarding Forward-Looking Statements	45

38

Introduction

For purposes of this discussion, unless otherwise mentioned or unless the context indicates otherwise, “BHNY,” the “Company,” “we,” “our” and “us” refer to Brighthouse Life Insurance Company of NY (formerly, First MetLife Investors Insurance Company), a New York domiciled life insurance company. BHNY is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (together with its subsidiaries and affiliates, “Brighthouse”). Management’s narrative analysis of the results of operations is presented pursuant to General Instruction H(2)(a) of Form 10-Q. This narrative analysis should be read in conjunction with (i) the unaudited interim condensed financial statements and related notes included elsewhere herein; (ii) our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 6, 2019 (the “2018 Annual Report”); and (iii) our current reports on Form 8-K filed in 2019.

The term “Separation” refers to the separation of MetLife, Inc.’s (together with its subsidiaries and affiliates, “MetLife”) former Brighthouse Financial segment from MetLife’s other businesses and the creation of a separate, publicly traded company, Brighthouse Financial, Inc. (we use the term “BHF” to refer solely to Brighthouse Financial, Inc., and not to any of its subsidiaries), as well as the distribution on August 4, 2017 of 96,776,670, or 80.8%, of the 119,773,106 shares of BHF common stock outstanding immediately prior to the distribution date by MetLife, Inc. to holders of MetLife, Inc. common stock as of the record date for the distribution. The term “MetLife Divestiture” refers to the disposition by MetLife, Inc. on June 14, 2018 of all its remaining shares of BHF common stock. Effective with the MetLife Divestiture, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties to Brighthouse Financial, Inc. and its subsidiaries and affiliates.

Overview

We offer a range of individual annuities and individual life insurance products in New York. For operating purposes, we have established two segments: Annuities and Life. In addition, we report certain of our results of operations in Corporate & Other. See “Business — Segments and Corporate & Other” included in the 2018 Annual Report along with Note 2 of the Notes to the Interim Condensed Financial Statements for further information on our segments and Corporate & Other.

See Note 1 of the Notes to the Interim Condensed Financial Statements for information regarding the adoption of new accounting pronouncements in 2019.

Summary of Critical Accounting Estimates

The preparation of financial statements in conformity withthe application of accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Interim Condensed Financial Statements.

The most critical estimates include those used in determining: 

(i) liabilities for future policy benefits;

(ii) accounting for reinsurance;

(iii) capitalization and amortization of deferred policy acquisition costs (“DAC”) and amortization of value of business acquired (“VOBA”);

(iv) estimated fair values of investments in the absence of quoted market values;

(v) investment impairments;

(vi) estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;

(vii) measurement of income taxes and the valuation of deferred tax assets; and

(viii) liabilities for litigation and regulatory matters.

In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations. Actual results could differ from these estimates.

The above critical accounting estimates are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” andNote 1 of the Notes to the Financial Statements included in the 2018 Annual Report.

39

Non-GAAP and Other Financial Disclosures

Our definitions of the non-GAAP and other financial measures may differ from those used by other companies.

Non-GAAP Financial Disclosures

Adjusted Earnings

In this report, we present adjusted earnings as a measure of our performance that is not calculated in accordance with GAAP. We believe that this non-GAAP financial measure highlights our results of operations and the underlying profitability drivers of our business, as well as enhances the understanding of our performance by the investor community. However, adjusted earnings should not be viewed as a substitute for net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP. See “— Results of Operations” for a reconciliation of adjusted earnings to net income (loss).

Adjusted earnings, which may be positive or negative, is used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. This financial measure focuses on our primary businesses principally by excluding the impact of market volatility, which could distort trends.

The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”); and

• Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).

The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:

• Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and

• Amortization of DAC and VOBA related to (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.

The tax impact of the adjustments mentioned is calculated net of the statutory tax rate, which could differ from our effective tax rate.

40

We present adjusted earnings in a manner consistent with management’s view of the primary business activities that drive the profitability of our core businesses. The following table illustrates how each component of adjusted earnings is calculated from the GAAP statement of operations line items:

Component of Adjusted Earnings		How Derived from GAAP (1)
(i)	Fee income	(i)	Universal life and investment-type policy fees (excluding (a) unearned revenue adjustments related to net investment gains (losses) and net derivative gains (losses) and (b) GMIB Fees) plusOther revenues(excluding other revenues associated with related party reinsurance) and amortization of deferred gain on reinsurance.
(ii)	Net investment spread	(ii)	Net investment income plus Investment Hedge Adjustments and interest received on ceded fixed annuity reinsurance deposit funds reduced by Interest credited to policyholder account balances and interest on future policy benefits.
(iii)	Insurance-related activities	(iii)	Premiums less Policyholder benefits and claims (excluding (a) GMIB Costs, (b) Market Value Adjustments, (c) interest on future policy benefits and (d) amortization of deferred gain on reinsurance) plus the pass through of performance of ceded separate account assets.
(iv)	Amortization of DAC and VOBA	(iv)	Amortization of DAC and VOBA (excluding amounts related to (a) net investment gains (losses), (b) net derivative gains (losses), (c) GMIB Fees and GMIB Costs and (d) Market Value Adjustments).
(v)	Other expenses, net of DAC capitalization	(v)	Other expensesreduced by capitalization of DAC.
(vi)	Provision for income tax expense (benefit)	(vi)	Tax impact of the above items.

______________

(1) Italicized items indicate GAAP statement of operations line items.

Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance. Accordingly, we report adjusted earnings by segment in Note 2 of the Notes to the Interim Condensed Financial Statements.

Other Financial Disclosures

We sometimes refer to sales activity for various products. Statistical sales information for life sales are calculated using the LIMRA (Life Insurance Marketing and Research Association) definition of sales for core direct sales, excluding company sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life insurance. Annuity sales consist of 10% of direct statutory premiums, excluding company sponsored internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

41

Results of Operations

Results for the Three Months Ended March 31, 2019 and 2018

Business Overview.Annuity sales increased 19% for thethree monthsendedMarch 31, 2019, compared to thethree monthsendedMarch 31, 2018. This increase resulted primarily from sales of our structured annuities consisting of products marketed under various names (collectively, “Shield Annuities”).

A significant portion of our net income is driven by separate account balances, particularly in our variable annuity business. Most directly, these balances determine asset-based fee income, but also impact DAC amortization and asset-based commissions. Separate account balances are driven by sales, movements in the market, surrenders, withdrawals, benefit payments, transfers and policy charges. Average separate account balances increased in the current period, compared to the prior period, due to an increase in equity market performance, partially offset by negative net flows and policy charges.

Unless otherwise noted, all amounts in the following discussions of our results of operations are stated before income tax except for adjusted earnings, which are presented net of income tax.

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Revenues
Premiums	$	9,032		$	10,293
Universal life and investment-type product policy fees	23,250			25,986
Net investment income	26,493			23,931
Other revenues	(20,323		)	(12,544		)
Net investment gains (losses)	(452		)	(2,355		)
Net derivative gains (losses)	(3,245		)	(44,262		)
Total revenues	34,755			1,049
Expenses
Policyholder benefits and claims	9,459			(1,541		)
Interest credited to policyholder account balances	8,258			9,232
Capitalization of DAC	(8,689		)	(8,116		)
Amortization of DAC and VOBA	903			(3,323		)
Other expenses	27,579			23,843
Total expenses	37,510			20,095
Income (loss) before provision for income tax	(2,755		)	(19,046		)
Provision for income tax expense (benefit)	(1,244		)	(4,676		)
Net income (loss)	$	(1,511	)	$	(14,370	)

42

The table below shows the components of net income (loss).

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
GMLB Riders	$	11,599		$	(27,886	)
Other derivative instruments	(4,552		)	(4,898		)
Net investment gains (losses)	(452		)	(2,355		)
Other adjustments	438			387
Pre-tax adjusted earnings	(9,788		)	15,706
Income (loss) before provision for income tax	(2,755		)	(19,046		)
Provision for income tax expense (benefit)	(1,244		)	(4,676		)
Net income (loss)	$	(1,511	)	$	(14,370	)

Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018

Net loss before provision for income tax was $2.8 million ($1.5 million, net of income tax), a decrease in the loss of $16.3 million (decrease in the loss of $12.9 million, net of income tax) from a loss before provision for income tax of $19.0 million ($14.4 million, net of income tax) in the prior period.

The improvement in income before provision for income tax was primarily due to:

• net favorable changes in guaranteed minimum living benefits (“GMLB”) Riders driven by:

◦ the impact of our direct variable annuity riders, primarily driven by higher equity markets; and

◦ the impact of our ceded variable annuity riders, primarily driven by lower interest rates;

partially offset by

◦ an unfavorable change in the fair value of the Shield Annuities embedded derivatives from higher equity markets, partially offset by the favorable change in the equity options hedging this change in fair value;

• lower net investment losses reflecting lower current period net losses on the sale of fixed maturity securities compared to the prior period.

The decrease in the loss before provision for income tax was partially offset by lower adjusted earnings discussed in greater detail below.

The provision for income tax in the current period led to an effective tax rate of 45%, compared to 25% in the prior period and primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

Reconciliation of Net Income (Loss) to Adjusted Earnings

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net income (loss)	$	(1,511	)	$	(14,370	)
Add: Provision for income tax expense (benefit)	(1,244		)	(4,676		)
Income (loss) before provision for income tax	(2,755		)	(19,046		)
Less: GMLB Riders	11,599			(27,886		)
Less: Other derivative instruments	(4,552		)	(4,898		)
Less: Net investment gains (losses)	(452		)	(2,355		)
Less: Other adjustments	438			387
Pre-tax adjusted earnings	(9,788		)	15,706
Less: Provision for income tax expense (benefit)	(2,721		)	2,621
Adjusted earnings	$	(7,067	)	$	13,085

43

Results for the Three Months Ended March 31, 2019 and 2018— Adjusted Earnings

The following table presents the components of adjusted earnings:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Fee income	$	33,251		$	37,684
Net investment spread	13,774			10,261
Insurance-related activities	(29,725		)	(8,831		)
Amortization of DAC and VOBA	(8,198		)	(7,681		)
Other expenses, net of DAC capitalization	(18,890		)	(15,727		)
Pre-tax adjusted earnings	(9,788		)	15,706
Provision for income tax expense (benefit)	(2,721		)	2,621
Adjusted earnings	$	(7,067	)	$	13,085

Three Months Ended March 31, 2019 Compared with the Three Months Ended March 31, 2018

Adjusted earnings decreased $20.2 million.

Key net unfavorable impacts were:

• higher costs associated with insurance-related activities due to:

◦ higher reserves in the current period on yearly renewable term business reinsured to an affiliate, and

◦ unfavorable change in the fair value of the underlying ceded separate account assets under a related party reinsurance agreement for certain variable annuity contracts;

• lower fee income due to lower asset-based fees resulting from lower average separate account balances; and

• higher other expenses due to:

◦ a change in allocation between legal entities; and

◦ higher costs following the Separation;

partially offset by

◦ lower asset-based variable annuity expenses resulting from lower average separate account balances.

The decrease in adjusted earnings was partially offset by higher net investment spread reflecting higher average invested assets resulting from positive net flows in the general account.

The provision for income tax in the current period led to an effective tax rate of 28%, compared to 17% in the prior period. Our effective tax rate primarily differs from the statutory tax rate due to the impacts of the dividends received deductions and tax credits.

44

Note Regarding Forward-Looking Statements

This report, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as “anticipate,” “estimate,” “expect,” “project,” “may,” “will,” “could,” “intend,” “goal,” “target,” “guidance,” “forecast,” “preliminary,” “objective,” “continue,” “aim,” “plan,” “believe” and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operating and financial results, as well as statements regarding the expected benefits of the Separation.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of BHNY. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others:

• differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models;

• higher risk management costs and exposure to increased market and counterparty risk due to guarantees within certain of our products;

• the potential material adverse effect of changes in accounting standards, practices and/or policies applicable to us including changes in the accounting for long-duration contracts;

• the effect adverse capital and credit market conditions may have on our ability to meet liquidity needs and our access to capital;

• the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations;

• the effectiveness of our risk management policies and procedures;

• the availability of reinsurance and the ability of our counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder;

• heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, financial strength ratings, e-business capabilities and name recognition;

• our ability to market and distribute our products through distribution channels;

• any failure of third parties to provide services we need, any failure of the practices and procedures of these third parties and any inability to obtain information or assistance we need from third parties, including MetLife;

• whether all or any portion of the tax consequences of the Separation are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us;

• the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements, including the potential of outcomes adverse to us that could cause us to owe MetLife material tax reimbursements or payments, or disagreements regarding MetLife’s or our obligations under our other agreements;

• the impact on our business structure, profitability, cost of capital and flexibility due to restrictions we have agreed to that preserve the tax-free treatment of certain parts of the Separation;

• the potential material negative tax impact of potential future tax legislation that could decrease the value of our tax attributes and cause other cash expenses, such as reserves, to increase materially and make some of our products less attractive to consumers;

• whether the Separation will qualify for non-recognition treatment for federal income tax purposes and potential indemnification to MetLife if the Separation does not so qualify;

45

• the impact of the Separation on our business and profitability due to MetLife’s strong brand and reputation, the increased costs related to replacing arrangements with MetLife with those of third parties and incremental costs as a public company;

• whether the operational, strategic and other benefits of the Separation can be achieved, and our ability to implement our business strategy;

• our ability to attract and retain key personnel; and

• other factors described in our 2018 Annual Report and from time to time in documents that we file with the SEC.

For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our 2018 Annual Report, particularly in the sections entitled “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk,” as well as in our subsequent SEC filings. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.

46

Item 4. Controls and Procedures

Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of March 31, 2019.

MetLife provides certain services to the Company on a transitional basis through services agreements. The Company continues to change business processes, implement systems and establish new third-party arrangements, as a subsidiary of Brighthouse Financial, Inc. In the first quarter of 2019, the Company implemented certain accounting systems independent of MetLife. We consider these to be material changes in our internal control over financial reporting.

Other than as noted above, there were no changes to the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

47

Part II — Other Information

Item 1. Legal Proceedings

See Note 9 of the Notes to the Interim Condensed Financial Statements included in this report. There have been no new material legal proceedings and no material developments in legal proceedings previously disclosed in the 2018 Annual Report.

Item 1A. Risk Factors

We discuss in this report, in the 2018 Annual Report and in our other filings with the SEC, various risks that may materially affect our business. In addition, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Note Regarding Forward-Looking Statements” included in this report. There have been no material changes to our risk factors from the risk factors previously disclosed in the 2018 Annual Report.

48

Item 6. Exhibits

(Note Regarding Reliance on Statements in Our Contracts: In reviewing the agreements included as exhibits herein, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about Brighthouse Life Insurance Company of NY, its affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about Brighthouse Life Insurance Company of NY may be found elsewhere herein and Brighthouse Life Insurance Company of NY’s other public filings, which are available without charge through the U.S. Securities and Exchange Commission website at www.sec.gov.)

Exhibit No.	Description
10.1	Investment Management Agreement, dated as of February 5, 2019, between Brighthouse Services, LLC and MetLife Investment Advisors, LLC (Incorporated by reference to Exhibit 10.1 to Form 8-K, filed by Brighthouse Life Insurance Company of NY on February 8, 2019).
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document.
101.SCH*	XBRL Taxonomy Extension Schema Document.
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document.

* Filed herewith.

49

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BRIGHTHOUSE LIFE INSURANCE COMPANY OF NY
By:		/s/ Lynn A. Dumais
	Name:	Lynn A. Dumais
	Title:	Vice President and Chief Financial Officer
		(Authorized Signatory and Principal Financial Officer)

Date: May 9, 2019

50

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Conor E. Murphy, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Brighthouse Life Insurance Company of NY;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2019

/s/ Conor E. Murphy

Conor E. Murphy

Chairman of the Board, President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Lynn A. Dumais, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Brighthouse Life Insurance Company of NY;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2019

/s/ Lynn A. Dumais

Lynn A. Dumais

Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

SECTION 906 CERTIFICATION

CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE

I, Conor E. Murphy, certify that, to my knowledge, (i) Brighthouse Life Insurance Company of NY’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Brighthouse Life Insurance Company of NY.

Date: May 9, 2019

/s/ Conor E. Murphy

Conor E. Murphy

Chairman of the Board, President and Chief Executive Officer

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by Brighthouse Life Insurance Company of NY (the “Company”) for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-32.2

Exhibit 32.2

SECTION 906 CERTIFICATION

CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE

I, Lynn A. Dumais, certify that, to my knowledge, (i) Brighthouse Life Insurance Company of NY’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Brighthouse Life Insurance Company of NY.

Date: May 9, 2019

/s/ Lynn A. Dumais

Lynn A. Dumais
Vice President and Chief Financial Officer

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by Brighthouse Life Insurance Company of NY (the “Company”) for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 09, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	BRIGHTHOUSE LIFE INSURANCE Co OF NY
Entity Central Index Key	0001167609
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		200,000

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $2,623,070 and $2,469,801, respectively)	$ 2,664,864	$ 2,433,633
Mortgage loans (net of valuation allowances of $2,006 and $1,937, respectively)	467,193	448,105
Other invested assets, principally at estimated fair value	48,176	35,815
Total investments	3,180,233	2,917,553
Cash and cash equivalents	208,781	120,130
Accrued investment income	22,784	20,605
Premiums, reinsurance and other receivables	574,277	580,480
Deferred policy acquisition costs and value of business acquired	178,073	185,586
Other assets	33,133	37,348
Separate account assets	4,559,757	4,268,423
Total assets	8,757,038	8,130,125
Liabilities
Future policy benefits	723,951	718,599
Policyholder account balances	1,812,080	1,692,498
Other policy-related balances	9,033	9,288
Payables For Collateral Under Securities Loaned And Other Transactions	36,791	23,581
Current income tax payable	1,804	1,755
Deferred income tax liability	118,816	107,853
Other liabilities	538,759	471,490
Separate account liabilities	4,559,757	4,268,423
Total liabilities	7,800,991	7,293,487
Contingencies, Commitments and Guarantees (Note 9)
Stockholder's Equity
Common stock, par value $10 per share; 200,000 shares authorized, issued and outstanding	2,000	2,000
Additional paid-in capital	490,931	415,931
Retained earnings (deficit)	432,267	433,778
Accumulated other comprehensive income (loss)	30,849	(15,071)
Total stockholder's equity	956,047	836,638
Total liabilities and stockholder's equity	$ 8,757,038	$ 8,130,125

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets
Amortized cost of fixed maturity securities available-for-sale	$ 2,623,070	$ 2,469,801
Mortgage loans valuation allowances	$ 2,006	$ 1,937
Stockholder's Equity
Common stock, par value	$ 10	$ 10
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	200,000	200,000
Common stock, shares outstanding	200,000	200,000

XML

Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues
Premiums	$ 9,032	$ 10,293
Universal life and investment-type product policy fees	23,250	25,986
Net investment income	26,493	23,931
Other revenues	(20,323)	(12,544)
Net investment gains (losses)	(452)	(2,355)
Net derivative gains (losses)	(3,245)	(44,262)
Total revenues	34,755	1,049
Expenses
Policyholder benefits and claims	9,459	(1,541)
Interest credited to policyholder account balances	8,258	9,232
Amortization of deferred policy acquisition costs and value of business acquired	903	(3,323)
Other expenses	18,890	15,727
Total expenses	37,510	20,095
Income (loss) before provision for income tax	(2,755)	(19,046)
Provision for income tax expense (benefit)	(1,244)	(4,676)
Net income (loss)	(1,511)	(14,370)
Comprehensive income (loss)	$ 44,409	$ (44,660)

XML

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2017	$ 843,487	$ 2,000	$ 415,931	$ 395,928	$ 29,628
Net income (loss)	(14,370)			(14,370)
Other comprehensive income (loss), net of income tax	(30,290)				(30,290)
Ending Balance at Mar. 31, 2018	798,827	2,000	415,931	381,558	(662)
Beginning Balance at Dec. 31, 2018	836,638	2,000	415,931	433,778	(15,071)
Net income (loss)	(1,511)			(1,511)
Capital contribution	75,000		75,000
Other comprehensive income (loss), net of income tax	45,920				45,920
Ending Balance at Mar. 31, 2019	$ 956,047	$ 2,000	$ 490,931	$ 432,267	$ 30,849

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities	$ 3,673	$ 23,949
Cash flows from investing activities
Sales, maturities and repayments of fixed maturity securities	70,442	77,753
Sales, maturities and repayments of mortgage loans	1,618	2,399
Purchases of fixed maturity securities	(157,155)	(141,218)
Purchases of mortgage loans	(22,322)	(14,445)
Cash received in connection with freestanding derivatives	23,716	212
Cash paid in connection with freestanding derivatives	(2,827)	(29,892)
Net change in short-term investments	3	(7,978)
Net change in other invested assets	6,943	425
Net cash provided by (used in) investing activities	(79,582)	(112,744)
Cash flows from financing activities
Policyholder account balances: Deposits	131,693	117,755
Policyholder account balances: Withdrawals	(55,343)	(33,962)
Net change in payables for collateral under derivative transactions	13,210	10,830
Capital contribution	75,000	0
Net cash provided by (used in) financing activities	164,560	94,623
Change in cash, cash equivalents and restricted cash	88,651	5,828
Cash, cash equivalents and restricted cash, beginning of period	120,130	86,154
Cash, cash equivalents and restricted cash, end of period	208,781	91,982
Supplemental disclosures of cash flow information
Net cash paid (received) for income tax	$ 0	$ 4

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business, Basis of Presentation and Summary of Significant Accounting Policies

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“BHNY” and the “Company” refer to Brighthouse Life Insurance Company of NY, a New York domiciled life insurance company. Brighthouse Life Insurance Company of NY is a wholly-owned subsidiary of Brighthouse Life Insurance Company, which is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. (“BHF” together with its subsidiaries and affiliates, “Brighthouse Financial”). The Company is licensed to transact business in the state of New York.

BHNY markets and/or administers traditional life, universal life, variable annuity and fixed annuity products to individuals. The Company is organized into two segments: Annuities; and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

In 2016, MetLife, Inc. (together with its subsidiaries and affiliates, “MetLife”) announced its plan to pursue the separation of a substantial portion of its former U.S. retail business (the “Separation”). In connection with the Separation,80.8% of MetLife, Inc.’s interest in BHF was distributed to holders of MetLife, Inc.’s common stock. On June 14, 2018, MetLife, Inc. divested its remaining shares of BHF common stock (the “MetLife Divestiture”). As a result, MetLife, Inc. and its subsidiaries and affiliates are no longer considered related parties subsequent to the MetLife Divestiture.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Reclassifications

Certain amounts in the prior year periods’ interim condensed financial statements and related footnotes thereto have been reclassified to conform with the 2019 presentation as may be discussed throughout the Notes to the Interim Condensed Financial Statements.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

The accompanying interim condensed financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2018 balance sheet data was derived from audited financial statements included in BHNY’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed financial statements should be read in conjunction with the financial statements of the Company included in the 2018 Annual Report.

Adoption of New Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s financial statements. There were no ASUs adopted during the first quarter of 2019 which had a material impact on the Company’s financial statements.

ASUs issued but not yet adopted as of March 31, 2019 are summarized in the table below.

Standard	Description	Effective Date	Impact on Financial Statements
ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts	The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (1) require all guarantees that qualify as market risk benefits to be measured at fair value, (2) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (3) modify the methods of amortization for deferred acquisition costs, and (4) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances.	January 1, 2021 using a modified retrospective method for the new market risk benefit guidance and prospective methods for the increased frequency of updating assumptions, the new discount rate requirements and deferred policy acquisition costs (“DAC”) amortization changes. Early adoption is permitted.	The Company is in the early stages of evaluating the new guidance and therefore is unable to estimate the impact to its financial statements. The most significant impact will be the measurement of liabilities for variable annuity guarantees.
ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments	The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than- temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses.	January 1, 2020 using the modified retrospective method (with early adoption permitted beginning January 1, 2019)	The Company is currently evaluating the impact of this guidance on its financial statements, with the most significant impact expected to be earlier recognition of credit losses on mortgage loan investments.

XML

Segment Information

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Information

2. Segment Information

The Company is organized into two segments: Annuities and Life. In addition, the Company reports certain of its results of operations in Corporate & Other.

Annuities

The Annuities segment consists of a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security.

Life

The Life segment consists of insurance products and services, including term, whole and universal life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis.

Corporate & Other

Corporate & Other contains the excess capital not allocated to the segments and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts and a portion of MetLife’s former U.S. insurance business sold direct to consumers, which is no longer being offered for new sales.

Financial Measures and Segment Accounting Policies

Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. Consistent with GAAP guidance for segment reporting, adjusted earnings is also used to measure segment performance. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Adjusted earnings should not be viewed as a substitute for net income (loss).

Adjusted earnings, which may be positive or negative, focuses on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends.

The following are significant items excluded from total revenues, net of income tax, in calculating adjusted earnings:

• Net investment gains (losses);

• Net derivative gains (losses) except earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment; and

• Certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”) and amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses).

The following are significant items excluded from total expenses, net of income tax, in calculating adjusted earnings:

• Amounts associated with benefits and hedging costs related to GMIBs (“GMIB Costs”);

• Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and

• Amortization of DAC and value of business acquired related to: (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.

The tax impact of the adjustments mentioned above is calculated net of the statutory tax rate, which could differ from the Company’s effective tax rate.

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months ended March 31, 2019 and 2018 and at March 31, 2019 and December 31, 2018. The segment accounting policies are the same as those used to prepare the Company’s condensed financial statements, except for the adjustments to calculate adjusted earnings described above. In addition, segment accounting policies include the methods of capital allocation described below.

Segment investment and capitalization targets are based on statutory oriented risk principles and metrics. Segment invested assets backing liabilities are based on net statutory liabilities plus excess capital. For the variable annuity business, the excess capital held is based on the target statutory total asset requirement consistent with the Company’s variable annuity risk management strategy. For insurance businesses other than variable annuities, excess capital held is based on a percentage of required statutory risk-based capital. Assets in excess of those allocated to the segments, if any, are held in Corporate & Other. Segment net investment income reflects the performance of each segment’s respective invested assets.

	Operating Results
Three Months Ended March 31, 2019	Annuities			Life			Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	(4,979	)	$	(4,256	)	$	(553	)	$	(9,788	)
Provision for income tax expense (benefit)	(1,468		)	(894		)	(359		)	(2,721		)
Adjusted earnings	$	(3,511	)	$	(3,362	)	$	(194	)	(7,067		)
Adjustments for:
Net investment gains (losses)										(452		)
Net derivative gains (losses)										(3,245		)
Other adjustments to net income										10,730
Provision for income tax (expense) benefit										(1,477		)
Net income (loss)										$	(1,511	)
Interest revenue	$	17,772		$	8,304		$	509

	Operating Results
Three Months Ended March 31, 2018	Annuities		Life		Corporate & Other		Total
	(In thousands)
Pre-tax adjusted earnings	$	5,430	$	8,014	$	2,262	$	15,706
Provision for income tax expense (benefit)	657		1,683		281		2,621
Adjusted earnings	$	4,773	$	6,331	$	1,981	13,085
Adjustments for:
Net investment gains (losses)							(2,355		)
Net derivative gains (losses)							(44,262		)
Other adjustments to net income							11,865
Provision for income tax (expense) benefit							7,297
Net income (loss)							$	(14,370	)
Interest revenue	$	14,803	$	8,839	$	371

The following table presents total revenues with respect to the Company’s segments, as well as Corporate & Other:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Annuities	$	21,887		$	27,638
Life	12,647			15,696
Corporate & Other	670			1,024
Adjustments	(449		)	(43,309		)
Total	$	34,755		$	1,049

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	March 31, 2019		December 31, 2018
	(In thousands)
Annuities	$	7,539,919	$	7,034,394
Life	1,124,314		1,083,641
Corporate & Other	92,805		12,090
Total	$	8,757,038	$	8,130,125

XML

Insurance

3 Months Ended

Mar. 31, 2019

Insurance [Abstract]

Insurance

3. Insurance

Guarantees

As discussed in Notes1and3of the Notes to the Financial Statements included in the 2018 Annual Report, the Company issues variable annuity contracts with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”), the non-life contingent portion of guaranteed minimum withdrawal benefits (“GMWBs”) and certain portions of GMIBs that do not require the policyholder to annuitize are accounted for as embedded derivatives in policyholder account balances and are further discussed inNote 5.

Information regarding the Company’s guarantee exposure was as follows at:

	March 31, 2019						December 31, 2018
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in thousands)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	4,564,444		$	3,703,604		$	4,274,326		$	3,483,668
Separate account value	$	4,557,551		$	3,702,932		$	4,266,520		$	3,482,829
Net amount at risk	$	22,344	(4)	$	211,888	(5)	$	193,102	(4)	$	274,632	(5)
Average attained age of contract holders	68 years			67 years			67 years			67 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, thenet amount at riskpresented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. SeeNote 5of the Notes to the Financial Statementsincluded in the2018Annual Report for a discussion ofguaranteed minimum benefitswhich have been reinsured.

(3) Includes the contract holder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.

XML

Investments

3 Months Ended

Mar. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Investments

4. Investments

See Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for a description of the Company’s accounting policies for investments and Note 6 for information about the fair value hierarchy for investments and the related valuation methodologies.

Fixed Maturity Securities Available-for-sale (“AFS”)

Fixed Maturity Securities AFS by Sector

The following table presents the fixed maturity securities AFS by sector at:

	March 31, 2019										December 31, 2018
	Amortized Cost		Gross Unrealized						Estimated Fair Value		Amortized Cost		Gross Unrealized						Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses						Gains		Temporary Losses		OTTI Losses
	(In thousands)
Fixed maturity securities: (1)
U.S. corporate	$	916,754	$	21,416	$	7,539	$	—	$	930,631	$	890,676	$	5,402	$	23,034	$	—	$	873,044
U.S. government and agency	504,101		15,524		4,269		—		515,356		511,255		9,961		13,697		—		507,519
Foreign corporate	374,509		6,641		7,194		—		373,956		368,149		1,473		17,258		—		352,364
CMBS	336,322		7,335		1,216		—		342,441		325,491		1,481		4,121		—		322,851
RMBS	315,454		6,879		1,973		—		320,360		200,827		4,643		2,882		—		202,588
ABS	83,618		262		489		—		83,391		79,806		158		1,133		—		78,831
State and political subdivision	65,995		6,168		70		—		72,093		66,131		4,777		1,083		—		69,825
Foreign government	26,317		692		373		—		26,636		27,466		140		995		—		26,611
Total fixed maturity securities	$	2,623,070	$	64,917	$	23,123	$	—	$	2,664,864	$	2,469,801	$	28,035	$	64,203	$	—	$	2,433,633

__________________

(1) Redeemable preferred stock is reported within foreign corporate fixed maturity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”).

The Company did not hold non-income producing fixed maturity securities at both March 31, 2019 and December 31, 2018.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at March 31, 2019:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In thousands)
Amortized cost	$	56,296	$	342,812	$	898,149	$	590,419	$	735,394	$	2,623,070
Estimated fair value	$	56,866	$	344,578	$	906,709	$	610,519	$	746,192	$	2,664,864

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	March 31, 2019								December 31, 2018
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in thousands)
Fixed maturity securities:
U.S. corporate	$	54,218	$	1,415	$	213,094	$	6,124	$	483,424	$	15,849	$	131,812	$	7,185
U.S. government and agency	—		—		264,905		4,269		102,447		1,925		296,265		11,772
Foreign corporate	68,008		3,251		102,547		3,943		194,924		10,156		72,803		7,102
CMBS	8,975		58		67,525		1,158		119,412		1,909		44,775		2,212
RMBS	72,806		130		46,591		1,843		57,510		1,746		28,573		1,136
ABS	39,489		389		11,104		100		51,028		985		11,699		148
State and political subdivision	6,175		25		7,815		45		18,260		744		13,999		339
Foreign government	10,645		373		—		—		7,435		716		6,782		279
Total fixed maturity securities	$	260,316	$	5,641	$	713,581	$	17,482	$	1,034,440	$	34,030	$	606,708	$	30,173
Total number of securities in an unrealized loss position	108				181				364				146

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

Evaluation and Measurement Methodologies

Management considers a wide range of factors about the security issuer and uses its best judgment in evaluating the cause of the decline in the estimated fair value of the security and in assessing the prospects for near-term recovery. Inherent in management’s evaluation of the security are assumptions and estimates about the operations of the issuer and its future earnings potential. Considerations used in the impairment evaluation process include, but are not limited to: (i) the length of time and the extent to which the estimated fair value has been below amortized cost; (ii) the potential for impairments when the issuer is experiencing significant financial difficulties; (iii) the potential for impairments in an entire industry sector or sub-sector; (iv) the potential for impairments in certain economically depressed geographic locations; (v) the potential for impairments where the issuer, series of issuers or industry has suffered a catastrophic loss or has exhausted natural resources; (vi) whether the Company has the intent to sell or will more likely than not be required to sell a particular security before the decline in estimated fair value below amortized cost recovers; (vii) with respect to Structured Securities, changes in forecasted cash flows after considering the quality of underlying collateral, expected prepayment speeds, current and forecasted loss severity, consideration of the payment terms of the underlying assets backing a particular security, and the payment priority within the tranche structure of the security; (viii) the potential for impairments due to weakening of foreign currencies on non-functional currency denominated fixed maturity securities that are near maturity; and (ix) other subjective factors, including concentrations and information obtained from regulators and rating agencies.

For securities in an unrealized loss position, an OTTI is recognized in earnings when it is anticipated that the amortized cost will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the OTTI recognized in earnings is the entire difference between the security’s amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is recognized as an OTTI in earnings (“credit loss”). If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of OTTI related to other-than-credit factors (“noncredit loss”) is recorded in other comprehensive income (“OCI”).

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at March 31, 2019.

Gross unrealized losses on fixed maturity securities decreased$41.1 million during the three months ended March 31, 2019 to $23.1 million. The decrease in gross unrealized losses for the three months ended March 31, 2019 was primarily attributable to decreasing longer-term interest rates and narrowing credit spreads.

At March 31, 2019, $940 thousand of the total $23.1 million of gross unrealized losses were from one fixed maturity security with an unrealized loss position of 20% or more of amortized cost for six months or greater.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	March 31, 2019					December 31, 2018
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in thousands)
Mortgage loans:
Commercial	$	319,650		68.4	%	$	310,681		69.3	%
Agricultural	149,549			32.0		139,361			31.1
Subtotal	469,199			100.4		450,042			100.4
Valuation allowances (1)	(2,006		)	(0.4	)	(1,937		)	(0.4	)
Total mortgage loans, net	$	467,193		100.0	%	$	448,105		100.0	%

__________________

(1) The valuation allowances were primarily from collective evaluation (non-specific loan related).

Information on commercial and agricultural mortgage loans is presented in the tables below.

Valuation Allowance Methodology

Mortgage loans are considered to be impaired when it is probable that, based upon current information and events, the Company will be unable to collect all amounts due under the loan agreement. Specific valuation allowances are established using the same methodology for both portfolio segments as the excess carrying value of a loan over either (i) the present value of expected future cash flows discounted at the loan’s original effective interest rate, (ii) the estimated fair value of the loan’s underlying collateral if the loan is in the process of foreclosure or otherwise collateral dependent, or (iii) the loan’s observable market price. A common evaluation framework is used for establishing non-specific valuation allowances for both loan portfolio segments; however, a separate non-specific valuation allowance is calculated and maintained for each loan portfolio segment that is based on inputs unique to each loan portfolio segment. Non-specific valuation allowances are established for pools of loans with similar risk characteristics where a property-specific or market-specific risk has not been identified, but for which the Company expects to incur a credit loss. These evaluations are based upon several loan portfolio segment-specific factors, including the Company’s experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations are revised as conditions change and new information becomes available.

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in thousands)
March 31, 2019
Loan-to-value ratios:
Less than 65%	$	277,674	$	5,000	$	13,448	$	296,122	92.7	%
65% to 75%	19,240		—		—		19,240		6.0
76% to 80%	4,288		—		—		4,288		1.3
Total	$	301,202	$	5,000	$	13,448	$	319,650	100.0	%
December 31, 2018
Loan-to-value ratios:
Less than 65%	$	273,681	$	5,000	$	13,447	$	292,128	94.0	%
65% to 75%	14,257		—		—		14,257		4.6
76% to 80%	4,296		—		—		4,296		1.4
Total	$	292,234	$	5,000	$	13,447	$	310,681	100.0	%

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at: 

	March 31, 2019				December 31, 2018
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in thousands)
Loan-to-value ratios:
Less than 65%	$	141,731	94.8	%	$	133,884	96.1	%
65% to 75%	7,818		5.2		5,477		3.9
Total	$	149,549	100.0	%	$	139,361	100.0	%

Past Due, Nonaccrual and Modified Mortgage Loans

The Company has a high quality, well performing mortgage loan portfolio, with all mortgage loans classified as performing at both March 31, 2019 and December 31, 2018. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans — 60 days and agricultural mortgage loans — 90 days. The Company had no commercial or agricultural mortgage loans past due and no commercial or agricultural mortgage loans in nonaccrual status at either March 31, 2019 or December 31, 2018. During both the three months ended March 31, 2019 and 2018, the Company did not have any mortgage loans modified in a troubled debt restructuring.

Cash Equivalents

The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $0 and $89.9 million at March 31, 2019 and December 31, 2018, respectively.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity securities and the effect on DAC, deferred sales inducements (“DSI”) and future policy benefits, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in accumulated other comprehensive income (“AOCI”).

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	March 31, 2019			December 31, 2018
	(In thousands)
Fixed maturity securities	$	41,793		$	(36,166	)
Derivatives	4,756			5,791
Subtotal	46,549			(30,375		)
Amounts allocated from:
DAC and DSI	(7,500		)	11,299
Deferred income tax benefit (expense)	(8,200		)	4,005
Net unrealized investment gains (losses)	$	30,849		$	(15,071	)

The changes in net unrealized investment gains (losses) were as follows:

	Three Months Ended   March 31, 2019
	(In thousands)
Balance, December 31, 2018	$	(15,071	)
Unrealized investment gains (losses) during the period	76,924
Unrealized investment gains (losses) relating to:
DAC and DSI	(18,799		)
Deferred income tax benefit (expense)	(12,205		)
Balance, March 31, 2019	$	30,849
Change in net unrealized investment gains (losses)	$	45,920

Concentrations of Credit Risk

There were no investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, at both March 31, 2019 and December 31, 2018.

Invested Assets on Deposit and Pledged as Collateral

Invested assets on deposit and pledged as collateral are presented below at estimated fair value:

	March 31, 2019		December 31, 2018
	(In thousands)
Invested assets on deposit (regulatory deposits)	$	1,530	$	1,482
Invested assets pledged as collateral (1)	8,652		158
Total invested assets on deposit and pledged as collateral (2)	$	10,182	$	1,640

__________________

(1) The Company has pledged invested assets in connection with derivative transactions (see Note 5).

(2) The Company held no restricted cash at both March 31, 2019 and December 31, 2018.

Variable Interest Entities

The Company has invested in legal entities that are variable interest entities (“VIEs”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and the obligation to absorb losses, or the right to receive benefits that could potentially be significant to the VIE.

There were no material VIEs for which the Company has concluded that it is the primary beneficiary at March 31, 2019 or December 31, 2018.

The Company’s investments in unconsolidated VIEs are described below.

Fixed Maturity Securities

The Company invests in U.S. corporate bonds, foreign corporate bonds, and Structured Securities issued by VIEs. The Company is not obligated to provide any financial or other support to these VIEs, other than the original investment. The Company’s involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer, or investment manager, which are generally viewed as having the power to direct the activities that most significantly impact the economic performance of the VIE, nor does the Company function in any of these roles. The Company does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity; as a result, the Company has determined it is not the primary beneficiary, or consolidator, of the VIE. The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities AFS” for information on these securities.

	March 31, 2019				December 31, 2018
	Carrying Amount		Maximum Exposure to Loss		Carrying Amount		Maximum Exposure to Loss
	(In thousands)
Fixed maturity securities	$	489,002	$	480,919	$	409,699	$	409,699

Net Investment Income

The components of net investment income were as follows:

	Three Months Ended   March 31,
	2019		2018
	(In thousands)
Investment income:
Fixed maturity securities	$	22,913	$	20,365
Mortgage loans	3,899		4,191
Cash, cash equivalents and short-term investments	387		158
Other	350		96
Subtotal	27,549		24,810
Less: Investment expenses	1,056		879
Net investment income	$	26,493	$	23,931

See “— Related Party Investment Transactions” for discussion of related party investment expenses.

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Fixed maturity securities	$	(468	)	$	(2,839	)
Mortgage loans	(69		)	(82		)
Other	85			566
Total net investment gains (losses)	$	(452	)	$	(2,355	)

Gains (losses) from foreign currency transactions included within net investment gains (losses) were $10 thousand and $414 thousand for the three months ended March 31, 2019 and 2018, respectively.

Sales or Disposals of Fixed Maturity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as shown in the table below.

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Proceeds	$	55,477		$	53,561
Gross investment gains	$	150		$	15
Gross investment losses	(618		)	(2,854		)
Net investment gains (losses)	$	(468	)	$	(2,839	)

Related Party Investment Transactions

The Company receives investment administrative services from MetLife Investment Advisors, LLC, which was considered a related party investment manager until the completion of the MetLife Divestiture. The related investment administrative service charges were$0and$766 thousandfor thethree monthsendedMarch 31, 2019and 2018, respectively. All of the charges reported as related party activity in 2018 occurred prior to the MetLife Divestiture. See Note1regarding the MetLife Divestiture.

XML

Derivatives

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

5. Derivatives

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).

Hedge Accounting

The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable and index-linked annuities and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated and measured at fair value, separately from the host contract. The Company bifurcates embedded derivatives when a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument, the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and the underlying contract is not already measured at estimated fair value with changes recorded in earnings.

See “— Future Policy Benefit Liabilities and Policyholder Account Balances”, “— Index-Linked Annuities” and “— Reinsurance” in the Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps and option contracts.

Interest Rate Derivatives

The Company purchases interest rate caps to protect against rises in long-term interest rates. The Company utilizes interest rate caps in nonqualifying hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets denominated in foreign currencies.

In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and nonqualifying hedging relationships.

Equity Derivatives

The Company uses equity index options to reduce exposure to rising equity markets associated with fixed annuities with equity indexed returns. The Company utilizes equity index options in nonqualifying hedging relationships.

Primary Risks Managed by Derivatives

The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:

		March 31, 2019						December 31, 2018
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In thousands)
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency swaps	Foreign currency exchange rate	$	83,513	$	4,563	$	130	$	82,704	$	5,649	$	187
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate caps	Interest rate	800,000		4,772		—		800,000		9,284		—
Foreign currency swaps	Foreign currency exchange rate	17,892		3,191		96		28,133		3,395		144
Equity index options	Equity market	2,307,473		35,487		9,969		2,154,321		10,389		96
Total non-designated or nonqualifying derivatives		3,125,365		43,450		10,065		2,982,454		23,068		240
Total		$	3,208,878	$	48,013	$	10,195	$	3,065,158	$	28,717	$	427

The following tables present the amount and location of gains (losses) recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):

	Net Derivative Gains (Losses) Recognized for Derivatives (1), (4)			Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)		Net Investment Income (5)		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Three Months Ended March 31, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	—		$	—	$	270	$	(1,035	)
Total cash flow hedges	—			—		270		(1,035		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,512		)	—		—		—
Foreign currency exchange rate derivatives	(36		)	88		—		—
Equity derivatives	36,116			—		—		—
Embedded derivatives	(34,901		)	—		—		—
Total non-qualifying hedges	(3,333		)	88		—		—
Total	$	(3,333	)	$	88	$	270	$	(1,035	)
Three Months Ended March 31, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	6		$	—	$	186	$	(2,674	)
Total cash flow hedges	6			—		186		(2,674		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,002		)	—		—		—
Foreign currency exchange rate derivatives	(972		)	152		—		—
Equity derivatives	(8,736		)	—		—		—
Embedded derivatives	(30,710		)	—		—		—
Total non-qualifying hedges	(44,420		)	152		—		—
Total	$	(44,414	)	$	152	$	186	$	(2,674	)

______________

(1) Includes gains (losses) reclassified from AOCI primarily for terminated cash flow hedges.

(2) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships.

(3) All components of each derivative's gain or loss were included in the assessment of hedge effectiveness.

(4) Total net derivative gains (losses) were ($3.2) million and ($44.3) million for the three months ended March 31, 2019 and 2018 respectively.

(5) Total net investment income was ($452) thousand and ($2.4) million for the three months ended March 31, 2019 and 2018 respectively.

At March 31, 2019 and December 31, 2018, the balance in AOCI associated with foreign currency swaps designated and qualifying as cash flow hedges was $4.8 million and $5.8 million, respectively.

Counterparty Credit Risk

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by International Swaps and Derivatives Association, Inc. (“ISDA”) Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

See Note 6 for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	March 31, 2019						December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In thousands)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	48,331		$	10,160		$	29,006		$	411
Total gross estimated fair value of derivatives (1)	48,331			10,160			29,006			411
Amounts offset on the balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the balance sheets (1)	48,331			10,160			29,006			411
Gross amounts not offset on the balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(3,825		)	(3,825		)	(365		)	(365		)
Cash collateral: (3)
OTC-bilateral	(34,235		)	—			(23,197		)	—
Securities collateral: (4)
OTC-bilateral	(2,875		)	(6,335		)	(2,212		)	(46		)
Net amount after application of master netting agreements and collateral	$	7,396		$	—		$	3,232		$	—

______________

(1) At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $318 thousand and $289 thousand, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($35) thousand and ($16) thousand, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received is included in cash and cash equivalents or in short-term investments, and the obligation to return it is included in payables for collateral transactions on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $2.6 million and $384 thousand, respectively, and did not provide any excess cash collateral, which is not included in the table above due to the foregoing limitation.

(4) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but atMarch 31, 2019,noneof the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. AtMarch 31, 2019andDecember 31, 2018, the Company received excess securities collateral with an estimated fair value of$3.9 millionand$78 thousand, respectively, and provided excess securities collateral with an estimated fair value of$2.3 millionand$112 thousand, respectively, for its OTC-bilateral derivatives.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. In addition, the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’sInvestors ServiceandStandard & Poor’s Global Ratings500 Index. If a party’s financial strength or credit ratings were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

At March 31, 2019 and December 31, 2018, the Company held OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements with an estimated fair value of $6.3 million and $46 thousand, respectively. At March 31, 2019 and December 31, 2018, the Company provided collateral with an estimated fair value of $8.7 million and $158 thousand, respectively. The Company’s collateral agreements require both parties to be fully collateralized, as such, the Company would not be required to post additional collateral as a result of a downgrade in its financial strength rating.

Embedded Derivatives

The Company issues certain insurance contracts that contain embedded derivatives that are required to be separated from their host contracts and measured at fair value. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; related party ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; and fixed annuities with equity-indexed returns.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	March 31, 2019			December 31, 2018
		(In thousands)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	295,107		$	298,112
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	(33,520	)	$	(18,811	)
Fixed annuities with equity indexed returns	Policyholder account balances	66,887			5,617
Embedded derivatives within liability host contracts		$	33,367		$	(13,194	)

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net derivative gains (losses) (1), (2)	$	(34,901	)	$	(30,710	)

______________

(1) The valuation of direct guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($3.4) millionand($1.1) millionfor thethree months endedMarch 31, 2019, and2018, respectively. In addition, the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were$19.8 millionand($600) thousandfor thethree months endedMarch 31, 2019and2018, respectively.

(2) See Note 10 for discussion of related party net derivative gains (losses).

XML

Fair Value

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value

6. Fair Value

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, are presented below. Investments that do not have a readily determinable fair value and are measured at net asset value (or equivalent) as a practical expedient to estimated fair value are excluded from the fair value hierarchy.

	March 31, 2019
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	926,863	$	3,768	$	930,631
U.S. government and agency	391,637		123,719		—		515,356
Foreign corporate	—		363,999		9,957		373,956
CMBS	—		337,733		4,708		342,441
RMBS	—		320,360		—		320,360
ABS	—		77,922		5,469		83,391
State and political subdivision	—		72,093		—		72,093
Foreign government	—		26,636		—		26,636
Total fixed maturity securities	391,637		2,249,325		23,902		2,664,864
Derivative assets: (1)
Interest rate	—		4,772		—		4,772
Foreign currency exchange rate	—		7,754		—		7,754
Equity market	—		35,487		—		35,487
Total derivative assets	—		48,013		—		48,013
Embedded derivatives within asset host contracts (2)	—		—		295,107		295,107
Separate account assets	—		4,559,757		—		4,559,757
Total assets	$	391,637	$	6,857,095	$	319,009	$	7,567,741
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	226	$	—	$	226
Equity market	—		9,969		—		9,969
Total derivative liabilities	—		10,195		—		10,195
Embedded derivatives within liability host contracts (2)	—		—		33,367		33,367
Total liabilities	$	—	$	10,195	$	33,367	$	43,562

	December 31, 2018
	Fair Value Hierarchy
	Level 1		Level 2		Level 3			Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	869,498	$	3,546		$	873,044
U.S. government and agency	389,491		118,028		—			507,519
Foreign corporate	—		342,600		9,764			352,364
CMBS	—		318,120		4,731			322,851
RMBS	—		202,588		—			202,588
ABS	—		78,831		—			78,831
State and political subdivision	—		69,825		—			69,825
Foreign government	—		26,611		—			26,611
Total fixed maturity securities	389,491		2,026,101		18,041			2,433,633
Derivative assets: (1)
Interest rate	—		9,284		—			9,284
Foreign currency exchange rate	—		8,572		472			9,044
Equity market	—		10,389		—			10,389
Total derivative assets	—		28,245		472			28,717
Embedded derivatives within asset host contracts (2)	—		—		298,112			298,112
Separate account assets	—		4,268,423		—			4,268,423
Total assets	$	389,491	$	6,322,769	$	316,625		$	7,028,885
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	331	$	—		$	331
Equity market	—		96		—			96
Total derivative liabilities	—		427		—			427
Embedded derivatives within liability host contracts (2)	—		—		(13,194		)	(13,194		)
Total liabilities	$	—	$	427	$	(13,194	)	$	(12,767	)

______________

(1) Derivative assets are presented within other invested assets on the balance sheets and derivative liabilities are presented within other liabilities on the balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the balance sheets.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets.

Valuation Controls and Procedures

The Company monitors and provides oversight of valuation controls and policies for securities, mortgage loans and derivatives, which are primarily executed by its valuation service providers. The valuation methodologies used to determine fair values prioritize the use of observable market prices and market-based parameters and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. The valuation methodologies for securities, mortgage loans and derivatives are reviewed on an ongoing basis and revised when necessary. In addition, the Chief Accounting Officer periodically reports to the Audit Committee of Brighthouse Financial’s Board of Directors regarding compliance with fair value accounting standards.

The fair value of financial assets and financial liabilities is based on quoted market prices, where available. The Company assesses whether prices received represent a reasonable estimate of fair value through controls designed to ensure valuations represent an exit price. Valuation service providers perform several controls, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. Independent non-binding broker quotes, also referred to herein as “consensus pricing,” are used for non-significant portion of the portfolio. Prices received from independent brokers are assessed to determine if they represent a reasonable estimate of fair value by considering such pricing relative to the current market dynamics and current pricing for similar financial instruments.

Valuation service providers also apply a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained. If obtaining an independent non-binding broker quotation is unsuccessful, valuation service providers will use the last available price.

The Company reviews outputs of the valuation service providers’ controls and performs additional controls, including certain monthly controls, which include but are not limited to, performing balance sheet analytics to assess reasonableness of period to period pricing changes, including any price adjustments. Price adjustments are applied if prices or quotes received from independent pricing services or brokers are not considered reflective of market activity or representative of estimated fair value. The Company did not have significant price adjustments during the three months ended March 31, 2019.

Determination of Fair Value

Fixed Maturity Securities

The fair values for actively traded marketable bonds, primarily U.S. government and agency securities, are determined using the quoted market prices and are classified as Level 1 assets. For fixed maturity securities classified as Level 2 assets, fair values are determined using either a market or income approach and are valued based on a variety of observable inputs as described below.

U.S. corporate and foreign corporate securities:Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark yields, spreads off benchmark yields, new issuances, issuer rating, trades of identical or comparable securities, or duration. Privately-placed securities are valued using the additional key inputs: market yield curve, call provisions, observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer, and delta spread adjustments to reflect specific credit-related issues.

U.S. government and agency, state and political subdivision and foreign government securities:Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, benchmark U.S. Treasury yield or other yields, spread off the U.S. Treasury yield curve for the identical security, issuer ratings and issuer spreads, broker dealer quotes, and comparable securities that are actively traded.

Structured Securities:Fair value is determined using third-party commercial pricing services, with the primary inputs being quoted prices in markets that are not active, spreads for actively traded securities, spreads off benchmark yields, expected prepayment speeds and volumes, current and forecasted loss severity, ratings, geographic region, weighted average coupon and weighted average maturity, average delinquency rates and debt-service coverage ratios. Other issuance-specific information is also used, including, but not limited to; collateral type, structure of the security, vintage of the loans, payment terms of the underlying asset, payment priority within tranche, and deal performance.

Derivatives

The fair values for OTC-bilateral derivatives and OTC-cleared derivatives classified as Level 2 assets or liabilities, fair values are determined using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models which are based on market standard valuation methodologies and a variety of observable inputs.

The significant inputs to the pricing models for most OTC-bilateral derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income. 

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Embedded Derivatives

Embedded derivatives principally include certain direct variable annuity guarantees and certain affiliated ceded reinsurance agreements related to such variable annuity guarantees. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the balance sheets.

The Company determines the fair value of these embedded derivatives by estimating the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations of policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates. The percentage of fees included in the initial fair value measurement is not updated in subsequent periods.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for BHF’s debt. These observable spreads are then adjusted to reflect the priority of these liabilities and claims paying ability of the issuing insurance subsidiaries as compared to BHF’s overall financial strength.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees.

Transfers Into or Out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					March 31, 2019			December 31, 2018			Impact of Increase in Input on Estimated Fair Value
	Valuation Techniques		Significant Unobservable Inputs		Range			Range
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates	0.02%	-	11.31%	0.02%	-	11%	Decrease (1)
			•	Lapse rates	0.25%	-	16%	0.25%	-	16%	Decrease (2)
			•	Utilization rates	0%	-	25%	0%	-	25%	Increase (3)
			•	Withdrawal rates	0.25%	-	10%	0.25%	-	10%	(4)
			•	Long-term equity volatilities	16.50%	-	22%	16.50%	-	22%	Increase (5)
			•	Nonperformance risk spread	1.31%	-	2.45%	1.91%	-	2.66%	Decrease (6)

______________

(1) Mortality rates vary by age and by demographic characteristics such as gender. Range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.

(2) Range reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.

(3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder.

(4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The Company does not develop unobservable inputs used in measuring fair value for all other assets and liabilities classified within Level 3; therefore, these are not included in the table above. The other Level 3 assets and liabilities primarily included fixed maturity securities and derivatives. For fixed maturity securities valued based on non-binding broker quotes, an increase (decrease) in credit spreads would result in a higher (lower) fair value. For derivatives valued based on third-party pricing models, an increase (decrease) in credit spreads would generally result in a higher (lower) fair value.

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			Net Derivatives (2)			Net Embedded Derivatives (3)
	(In thousands)
Three Months Ended March 31, 2019
Balance, beginning of period	$	13,310		$	4,731		$	472		$	311,306
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	2			(32		)	—			(34,901		)
Total realized/unrealized gains (losses) included in AOCI	403			78			—			—
Purchases (6)	—			—			—			—
Sales (6)	(48		)	(29		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(14,665		)
Transfers into Level 3 (7)	263			5,429			—			—
Transfers out of Level 3 (7)	(205		)	—			(472		)	—
Balance, end of period	$	13,725		$	10,177		$	—		$	261,740
Three Months Ended March 31, 2018
Balance, beginning of period	$	95,950		$	19,557		$	—		$	347,633
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	1			109			—			(30,710		)
Total realized/unrealized gains (losses) included in AOCI	(772		)	119			—			—
Purchases (6)	783			1,955			—			—
Sales (6)	(716		)	(403		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(5,912		)
Transfers into Level 3 (7)	—			—			—			—
Transfers out of Level 3 (7)	(3,166		)	—			—			—
Balance, end of period	$	92,080		$	21,337		$	—		$	311,011
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2019 (8)	$	4		$	(32	)	$	—		$	13,080
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2018 (8)	$	1		$	109		$	—		$	(33,063	)

______________

(1) Comprised of U.S. and foreign corporate securities.

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

(5) Interest accruals, as well as cash interest coupons received, are excluded from the rollforward.

(6) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(7) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(8) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income and payables for collateral under derivative transactions. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	March 31, 2019
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	467,193	$	—	$	—	$	472,882	$	472,882
Premiums, reinsurance and other receivables	$	18,415	$	—	$	4,055	$	13,021	$	17,076
Liabilities
Policyholder account balances	$	1,014,394	$	—	$	—	$	938,827	$	938,827
Other liabilities	$	81,790	$	—	$	81,790	$	—	$	81,790

	December 31, 2018
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	448,105	$	—	$	—	$	447,510	$	447,510
Premiums, reinsurance and other receivables	$	20,001	$	—	$	2,314	$	15,512	$	17,826
Liabilities
Policyholder account balances	$	1,056,419	$	—	$	—	$	949,916	$	949,916
Other liabilities	$	10,399	$	—	$	10,399	$	—	$	10,399

XML

Equity

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Equity

7. Equity

Capital Transactions

During the three months ended March 31, 2019, the Company received a cash capital contribution of $75 million from Brighthouse Life Insurance Company.

Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI was as follows:

	Three Months Ended   March 31, 2019
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2018	$	(20,503	)	$	5,432		$	(15,071	)
OCI before reclassifications	58,689			(1,035		)	57,654
Deferred income tax benefit (expense)	(12,325		)	217			(12,108		)
AOCI before reclassifications, net of income tax	25,861			4,614			30,475
Amounts reclassified from AOCI	471			—			471
Deferred income tax benefit (expense)	(97		)	—			(97		)
Amounts reclassified from AOCI, net of income tax	374			—			374
Balance, March 31, 2019	$	26,235		$	4,614		$	30,849

	Three Months Ended   March 31, 2018
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2017	$	29,323		$	305		$	29,628
OCI before reclassifications	(38,499		)	(2,674		)	(41,173		)
Deferred income tax benefit (expense)	8,083			562			8,645
AOCI before reclassifications, net of income tax	(1,093		)	(1,807		)	(2,900		)
Amounts reclassified from AOCI	2,839			(6		)	2,833
Deferred income tax benefit (expense)	(596		)	1			(595		)
Amounts reclassified from AOCI, net of income tax	2,243			(5		)	2,238
Balance, March 31, 2018	$	1,150		$	(1,812	)	$	(662	)

______________

(1) See Note 4 for information on offsets to investments related to DAC and DSI.

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI						Statements of Operations and Comprehensive Income (Loss) Locations
	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	(465	)	$	(2,839	)	Net investment gains (losses)
Net unrealized investment gains (losses)	(6		)	—			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(471		)	(2,839		)
Income tax (expense) benefit	97			596
Net unrealized investment gains (losses), net of income tax	(374		)	(2,243		)
Unrealized gains (losses) on derivatives - cash flow hedges:
Foreign currency swaps	—			6			Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	—			6
Income tax (expense) benefit	—			(1		)
Gains (losses) on cash flow hedges, net of income tax	—			5
Total reclassifications, net of income tax	$	(374	)	$	(2,238	)

XML

Other Revenues and Other Expenses

3 Months Ended

Mar. 31, 2019

Other Income and Expenses [Abstract]

Other Revenues and Other Expenses

8. Other Revenues and Other Expenses

Other Revenues

The Company has entered into contracts with mutual funds, fund managers, and their affiliates (collectively, the “Funds”) whereby the Company is paid monthly or quarterly fees (“12b-1 fees”) for providing certain services to customers and distributors of the Funds. The 12b-1 fees are generally equal to a fixed percentage of the average daily balance of the customer’s investment in a fund. The percentage is specified in the contract between the Company and the Funds. Payments are generally collected when due and are neither refundable nor able to offset future fees.

To earn these fees, the Company performs services such as responding to phone inquiries, maintaining records, providing information to distributors and shareholders about fund performance and providing training to account managers and sales agents. The passage of time reflects the satisfaction of the Company’s performance obligations to the Funds and is used to recognize revenue associated with 12b-1 fees.

Other revenues consisted primarily of 12b-1 fees of $3.1 million and $3.5 million for the three months ended March 31, 2019 and 2018, respectively, of which all were reported in the Annuities segment.

Other Expenses

Information on other expenses was as follows:

	Three Months Ended   March 31,
	2019		2018
	(In thousands)
Compensation	$	4,667	$	3,510
Contracted services and other labor costs	2,596		1,837
Transition services agreements	3,784		2,947
Establishment costs	1,482		—
Premium and other taxes, licenses and fees	704		1,043
Volume related costs, excluding compensation, net of DAC capitalization	3,998		5,264
Other	1,659		1,126
Total other expenses	$	18,890	$	15,727

Related Party Expenses

See Note 10 for a discussion of related party expenses included in the table above.

XML

Contingencies, Commitments and Guarantees

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Contingencies, Commitments and Guarantees

9. Contingencies, Commitments and Guarantees

Contingencies

Litigation

Sales Practices Claims

Over the past several years, the Company has faced claims and regulatory inquiries and investigations, alleging improper marketing or sales of individual life insurance policies, annuities, or other products. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its financial statements for all probable and reasonably estimable losses for sales practices matters.

Summary

Various litigation, claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, investor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, large and/or indeterminate amounts, including punitive and treble damages, are sought. Although, in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s net income or cash flows in particular quarterly or annual periods.

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $21.8 million and $7.6 million at March 31, 2019 and December 31, 2018, respectively.

Commitments to Fund Private Corporate Bond Investments

The Company commits to lend funds under private corporate bond investments. The amounts of these unfunded commitments were$3.5 millionand$11.4 millionatMarch 31, 2019andDecember 31, 2018, respectively.

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company had no liability for indemnities, guarantees and commitments at both March 31, 2019 and December 31, 2018.

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2019

Related Party Transactions [Abstract]

Related Party Transactions

10. Related Party Transactions

The Company has various existing arrangements with its Brighthouse affiliates and had previous arrangements with MetLife for services necessary to conduct its activities. Certain of the MetLife services have continued, however, MetLife was no longer considered a related party upon the completion of the MetLife Divestiture on June 14, 2018 (see Note 1). The Company has related party investment and equity transactions (see Notes 4 and 7). Other material arrangements between the Company and its related parties not disclosed elsewhere are as follows:

Reinsurance Agreements

The Company enters into reinsurance agreements primarily as a purchaser of reinsurance for its various insurance products. The Company participates in reinsurance activities in order to limit losses, minimize exposure to significant risks and provide additional capacity for future growth.

Information regarding the significant effects of related party reinsurance included on the interim condensed statements of operations and comprehensive income (loss) was as follows:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Premiums
Reinsurance ceded	$	(10,210	)	$	(8,112	)
Universal life and investment-type product policy fees
Reinsurance ceded	$	(803	)	$	(1,043	)
Other revenues
Reinsurance ceded	$	(23,508	)	$	(15,936	)
Policyholder benefits and claims
Reinsurance ceded	$	(8,213	)	$	(24,732	)

Information regarding the significant effects of ceded related party reinsurance included on the interim condensed balance sheets was as follows at:

	March 31, 2019		December 31, 2018
	(In thousands)
Assets
Premiums, reinsurance and other receivables	$	522,891	$	534,487
Liabilities
Other liabilities	$	420,568	$	429,656

The Company cedes risks to Brighthouse Life Insurance Company related to guaranteed minimum benefit guarantees written directly by the Company. These ceded reinsurance agreements contain embedded derivatives and changes in the estimated fair value are included within net derivative gains (losses). The embedded derivatives associated with the cessions are included within premiums, reinsurance and other receivables and were $295.1 million and $298.1 million at March 31, 2019 and December 31, 2018, respectively. Net derivative gains (losses) associated with the embedded derivatives were ($3.5) million and ($45.8) million for the three months ended March 31, 2019 and 2018, respectively.

Shared Services and Overhead Allocations

Brighthouse affiliates currently provide and previously MetLife provided the Company certain services, which include, but are not limited to, treasury, financial planning and analysis, legal, human resources, tax planning, internal audit, financial reporting and information technology. Costs incurred under these arrangements with Brighthouse affiliates, as well as with MetLife prior to the MetLife Divestiture, were $15.1 million and $9.7 million for the three months ended March 31, 2019 and 2018, respectively, and were recorded in other expenses. Revenues received from affiliates related to these agreements, recorded in universal life and investment-type product policy fees, were $2.9 million and $3.2 million for the three months ended March 31, 2019 and 2018, respectively.

The Company had net receivables (payables) from/to affiliates, related to the items discussed above, of ($941) thousand and $622 thousand at March 31, 2019 and December 31, 2018, respectively.

Brighthouse affiliates incur costs related to the establishment of services and infrastructure to replace those previously provided by MetLife. The Company is charged a fee to reflect the value of the available infrastructure and services provided by these costs. While management believes the method used to allocate expenses under this arrangement is reasonable, the allocated expenses may not be indicative of those of a stand-alone entity. If expenses were allocated to the Company under this arrangement as incurred by Brighthouse affiliates, the Company would have incurred additional expenses of ($260) thousand for the three months ended March 31, 2019. The Company would have incurred no additional expenses under this arrangement for the three months ended March 31, 2018.

Broker-Dealer Transactions

The related party expense for the Company was commissions collected on the sale of variable products by the Company and passed through to the broker-dealer. The related party revenue for the Company was fee income from trusts and mutual funds whose shares serve as investment options of policyholders of the Company.Fee income received from affiliates related to these transactions and recorded in other revenues was$2.8 millionand$3.2 millionfor thethree monthsendedMarch 31, 2019and2018, respectively. Commission expenses incurred from affiliates related to these transactions and recorded in other expenses was$14.7 millionand$13.1 millionfor thethree monthsendedMarch 31, 2019and2018, respectively. The Company also had related party fee income receivables of$993 thousandand$951 thousandatMarch 31, 2019andDecember 31, 2018, respectively.

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of Estimates, Policy [Policy Text Block]

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.

Consolidation of Subsidiaries, Policy [Policy Text Block]

Reclassifications

Certain amounts in the prior year periods’ interim condensed financial statements and related footnotes thereto have been reclassified to conform with the 2019 presentation as may be discussed throughout the Notes to the Interim Condensed Financial Statements.

Since the Company is a member of a controlled group of affiliated companies, its results may not be indicative of those of a stand-alone entity.

The accompanying interim condensed financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2018 balance sheet data was derived from audited financial statements included in BHNY’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed financial statements should be read in conjunction with the financial statements of the Company included in the 2018 Annual Report.

New Accounting Pronouncements, Policy [Policy Text Block]

Adoption of New Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are not expected to have a material impact on the Company’s financial statements. There were no ASUs adopted during the first quarter of 2019 which had a material impact on the Company’s financial statements.

ASUs issued but not yet adopted as of March 31, 2019 are summarized in the table below.

Standard	Description	Effective Date	Impact on Financial Statements
ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts	The amendments to Topic 944 will result in significant changes to the accounting for long-duration insurance contracts. These changes (1) require all guarantees that qualify as market risk benefits to be measured at fair value, (2) require more frequent updating of assumptions and modify existing discount rate requirements for certain insurance liabilities, (3) modify the methods of amortization for deferred acquisition costs, and (4) require new qualitative and quantitative disclosures around insurance contract asset and liability balances and the judgments, assumptions and methods used to measure those balances.	January 1, 2021 using a modified retrospective method for the new market risk benefit guidance and prospective methods for the increased frequency of updating assumptions, the new discount rate requirements and deferred policy acquisition costs (“DAC”) amortization changes. Early adoption is permitted.	The Company is in the early stages of evaluating the new guidance and therefore is unable to estimate the impact to its financial statements. The most significant impact will be the measurement of liabilities for variable annuity guarantees.
ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments	The amendments to Topic 326 replace the incurred loss impairment methodology for certain financial instruments with one that reflects expected credit losses based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance also requires that an other-than- temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses.	January 1, 2020 using the modified retrospective method (with early adoption permitted beginning January 1, 2019)	The Company is currently evaluating the impact of this guidance on its financial statements, with the most significant impact expected to be earlier recognition of credit losses on mortgage loan investments.

Investments, Policy [Policy Text Block]

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Past Due, Nonaccrual and Modified Mortgage Loans

The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial mortgage loans — 60 days and agricultural mortgage loans — 90 days.

Variable Interest Entities

The Company has invested in legal entities that are variable interest entities (“VIEs”). VIEs are consolidated when the investor is the primary beneficiary. A primary beneficiary is the variable interest holder in a VIE with both the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and the obligation to absorb losses, or the right to receive benefits that could potentially be significant to the VIE.

There were no material VIEs for which the Company has concluded that it is the primary beneficiary at March 31, 2019 or December 31, 2018.

Derivatives, Policy [Policy Text Block]

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).

Hedge Accounting

The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable and index-linked annuities and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated and measured at fair value, separately from the host contract. The Company bifurcates embedded derivatives when a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument, the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and the underlying contract is not already measured at estimated fair value with changes recorded in earnings.

See “— Future Policy Benefit Liabilities and Policyholder Account Balances”, “— Index-Linked Annuities” and “— Reinsurance” in the Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps and option contracts.

Derivative Strategies

Counterparty Credit Risk

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by International Swaps and Derivatives Association, Inc. (“ISDA”) Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Reporting Information, by Segment

	Operating Results
Three Months Ended March 31, 2019	Annuities			Life			Corporate & Other			Total
	(In thousands)
Pre-tax adjusted earnings	$	(4,979	)	$	(4,256	)	$	(553	)	$	(9,788	)
Provision for income tax expense (benefit)	(1,468		)	(894		)	(359		)	(2,721		)
Adjusted earnings	$	(3,511	)	$	(3,362	)	$	(194	)	(7,067		)
Adjustments for:
Net investment gains (losses)										(452		)
Net derivative gains (losses)										(3,245		)
Other adjustments to net income										10,730
Provision for income tax (expense) benefit										(1,477		)
Net income (loss)										$	(1,511	)
Interest revenue	$	17,772		$	8,304		$	509

	Operating Results
Three Months Ended March 31, 2018	Annuities		Life		Corporate & Other		Total
	(In thousands)
Pre-tax adjusted earnings	$	5,430	$	8,014	$	2,262	$	15,706
Provision for income tax expense (benefit)	657		1,683		281		2,621
Adjusted earnings	$	4,773	$	6,331	$	1,981	13,085
Adjustments for:
Net investment gains (losses)							(2,355		)
Net derivative gains (losses)							(44,262		)
Other adjustments to net income							11,865
Provision for income tax (expense) benefit							7,297
Net income (loss)							$	(14,370	)
Interest revenue	$	14,803	$	8,839	$	371

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	March 31, 2019		December 31, 2018
	(In thousands)
Annuities	$	7,539,919	$	7,034,394
Life	1,124,314		1,083,641
Corporate & Other	92,805		12,090
Total	$	8,757,038	$	8,130,125

Reconciliation of Revenue from Segments to Consolidated

The following table presents total revenues with respect to the Company’s segments, as well as Corporate & Other:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Annuities	$	21,887		$	27,638
Life	12,647			15,696
Corporate & Other	670			1,024
Adjustments	(449		)	(43,309		)
Total	$	34,755		$	1,049

XML

Insurance (Tables)

3 Months Ended

Mar. 31, 2019

Insurance [Abstract]

Guarantees related to Annuity, Universal and Variable Life Contracts

Information regarding the Company’s guarantee exposure was as follows at:

	March 31, 2019						December 31, 2018
	In the Event of Death			At Annuitization			In the Event of Death			At Annuitization
	(Dollars in thousands)
Annuity Contracts (1), (2)
Variable Annuity Guarantees
Total account value (3)	$	4,564,444		$	3,703,604		$	4,274,326		$	3,483,668
Separate account value	$	4,557,551		$	3,702,932		$	4,266,520		$	3,482,829
Net amount at risk	$	22,344	(4)	$	211,888	(5)	$	193,102	(4)	$	274,632	(5)
Average attained age of contract holders	68 years			67 years			67 years			67 years

______________

(1) The Company’s annuity contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes direct business, but excludes offsets from hedging or reinsurance, if any. Therefore, thenet amount at riskpresented reflects the economic exposures of living and death benefit guarantees associated with variable annuities, but not necessarily their impact on the Company. SeeNote 5of the Notes to the Financial Statementsincluded in the2018Annual Report for a discussion ofguaranteed minimum benefitswhich have been reinsured.

(3) Includes the contract holder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contract holders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contract holders have achieved.

XML

Investments (Tables)

3 Months Ended

Mar. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Fixed Maturity and Equity Securities Available-for-Sale

The following table presents the fixed maturity securities AFS by sector at:

	March 31, 2019										December 31, 2018
	Amortized Cost		Gross Unrealized						Estimated Fair Value		Amortized Cost		Gross Unrealized						Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses						Gains		Temporary Losses		OTTI Losses
	(In thousands)
Fixed maturity securities: (1)
U.S. corporate	$	916,754	$	21,416	$	7,539	$	—	$	930,631	$	890,676	$	5,402	$	23,034	$	—	$	873,044
U.S. government and agency	504,101		15,524		4,269		—		515,356		511,255		9,961		13,697		—		507,519
Foreign corporate	374,509		6,641		7,194		—		373,956		368,149		1,473		17,258		—		352,364
CMBS	336,322		7,335		1,216		—		342,441		325,491		1,481		4,121		—		322,851
RMBS	315,454		6,879		1,973		—		320,360		200,827		4,643		2,882		—		202,588
ABS	83,618		262		489		—		83,391		79,806		158		1,133		—		78,831
State and political subdivision	65,995		6,168		70		—		72,093		66,131		4,777		1,083		—		69,825
Foreign government	26,317		692		373		—		26,636		27,466		140		995		—		26,611
Total fixed maturity securities	$	2,623,070	$	64,917	$	23,123	$	—	$	2,664,864	$	2,469,801	$	28,035	$	64,203	$	—	$	2,433,633

__________________

(1) Redeemable preferred stock is reported within foreign corporate fixed maturity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and asset-backed securities (“ABS”) (collectively, “Structured Securities”).

Available-for-sale fixed maturity securities by contractual maturity date

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at March 31, 2019:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In thousands)
Amortized cost	$	56,296	$	342,812	$	898,149	$	590,419	$	735,394	$	2,623,070
Estimated fair value	$	56,866	$	344,578	$	906,709	$	610,519	$	746,192	$	2,664,864

Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale

The following table presents the estimated fair value and gross unrealized losses of fixed maturity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	March 31, 2019								December 31, 2018
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in thousands)
Fixed maturity securities:
U.S. corporate	$	54,218	$	1,415	$	213,094	$	6,124	$	483,424	$	15,849	$	131,812	$	7,185
U.S. government and agency	—		—		264,905		4,269		102,447		1,925		296,265		11,772
Foreign corporate	68,008		3,251		102,547		3,943		194,924		10,156		72,803		7,102
CMBS	8,975		58		67,525		1,158		119,412		1,909		44,775		2,212
RMBS	72,806		130		46,591		1,843		57,510		1,746		28,573		1,136
ABS	39,489		389		11,104		100		51,028		985		11,699		148
State and political subdivision	6,175		25		7,815		45		18,260		744		13,999		339
Foreign government	10,645		373		—		—		7,435		716		6,782		279
Total fixed maturity securities	$	260,316	$	5,641	$	713,581	$	17,482	$	1,034,440	$	34,030	$	606,708	$	30,173
Total number of securities in an unrealized loss position	108				181				364				146

Disclosure of Mortgage Loans Net of Valuation Allowance

Mortgage loans are summarized as follows at:

	March 31, 2019					December 31, 2018
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in thousands)
Mortgage loans:
Commercial	$	319,650		68.4	%	$	310,681		69.3	%
Agricultural	149,549			32.0		139,361			31.1
Subtotal	469,199			100.4		450,042			100.4
Valuation allowances (1)	(2,006		)	(0.4	)	(1,937		)	(0.4	)
Total mortgage loans, net	$	467,193		100.0	%	$	448,105		100.0	%

__________________

(1) The valuation allowances were primarily from collective evaluation (non-specific loan related).

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of agricultural mortgage loans was as follows at: 

	March 31, 2019				December 31, 2018
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in thousands)
Loan-to-value ratios:
Less than 65%	$	141,731	94.8	%	$	133,884	96.1	%
65% to 75%	7,818		5.2		5,477		3.9
Total	$	149,549	100.0	%	$	139,361	100.0	%

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in thousands)
March 31, 2019
Loan-to-value ratios:
Less than 65%	$	277,674	$	5,000	$	13,448	$	296,122	92.7	%
65% to 75%	19,240		—		—		19,240		6.0
76% to 80%	4,288		—		—		4,288		1.3
Total	$	301,202	$	5,000	$	13,448	$	319,650	100.0	%
December 31, 2018
Loan-to-value ratios:
Less than 65%	$	273,681	$	5,000	$	13,447	$	292,128	94.0	%
65% to 75%	14,257		—		—		14,257		4.6
76% to 80%	4,296		—		—		4,296		1.4
Total	$	292,234	$	5,000	$	13,447	$	310,681	100.0	%

Components of net unrealized investment gains (losses) included in accumulated other comprehensive income (loss)

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	March 31, 2019			December 31, 2018
	(In thousands)
Fixed maturity securities	$	41,793		$	(36,166	)
Derivatives	4,756			5,791
Subtotal	46,549			(30,375		)
Amounts allocated from:
DAC and DSI	(7,500		)	11,299
Deferred income tax benefit (expense)	(8,200		)	4,005
Net unrealized investment gains (losses)	$	30,849		$	(15,071	)

The changes in net unrealized investment gains (losses) were as follows:

	Three Months Ended   March 31, 2019
	(In thousands)
Balance, December 31, 2018	$	(15,071	)
Unrealized investment gains (losses) during the period	76,924
Unrealized investment gains (losses) relating to:
DAC and DSI	(18,799		)
Deferred income tax benefit (expense)	(12,205		)
Balance, March 31, 2019	$	30,849
Change in net unrealized investment gains (losses)	$	45,920

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

Invested assets on deposit and pledged as collateral are presented below at estimated fair value:

	March 31, 2019		December 31, 2018
	(In thousands)
Invested assets on deposit (regulatory deposits)	$	1,530	$	1,482
Invested assets pledged as collateral (1)	8,652		158
Total invested assets on deposit and pledged as collateral (2)	$	10,182	$	1,640

__________________

(1) The Company has pledged invested assets in connection with derivative transactions (see Note 5).

(2) The Company held no restricted cash at both March 31, 2019 and December 31, 2018.

Variable Interest Entities

The Company’s maximum exposure to loss on these fixed maturity securities is limited to the amortized cost of these investments. See “— Fixed Maturity Securities AFS” for information on these securities.

	March 31, 2019				December 31, 2018
	Carrying Amount		Maximum Exposure to Loss		Carrying Amount		Maximum Exposure to Loss
	(In thousands)
Fixed maturity securities	$	489,002	$	480,919	$	409,699	$	409,699

The Components of Net Investment Income

The components of net investment income were as follows:

	Three Months Ended   March 31,
	2019		2018
	(In thousands)
Investment income:
Fixed maturity securities	$	22,913	$	20,365
Mortgage loans	3,899		4,191
Cash, cash equivalents and short-term investments	387		158
Other	350		96
Subtotal	27,549		24,810
Less: Investment expenses	1,056		879
Net investment income	$	26,493	$	23,931

The components of net investment gains (losses)

The components of net investment gains (losses) were as follows:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Fixed maturity securities	$	(468	)	$	(2,839	)
Mortgage loans	(69		)	(82		)
Other	85			566
Total net investment gains (losses)	$	(452	)	$	(2,355	)

Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains and losses

Proceeds from sales or disposals of fixed maturity securities and the components of fixed maturity securities net investment gains (losses) were as shown in the table below.

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Proceeds	$	55,477		$	53,561
Gross investment gains	$	150		$	15
Gross investment losses	(618		)	(2,854		)
Net investment gains (losses)	$	(468	)	$	(2,839	)

XML

Derivatives (Tables)

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

5. Derivatives

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses).

Hedge Accounting

The Company primarily designates derivatives as a hedge of a forecasted transaction or a variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in fair value are recorded in OCI and subsequently reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable and index-linked annuities and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated and measured at fair value, separately from the host contract. The Company bifurcates embedded derivatives when a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument, the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract and the underlying contract is not already measured at estimated fair value with changes recorded in earnings.

See “— Future Policy Benefit Liabilities and Policyholder Account Balances”, “— Index-Linked Annuities” and “— Reinsurance” in the Note 1 of the Notes to the Financial Statements included in the 2018 Annual Report for additional information on the accounting policies for embedded derivatives bifurcated from variable annuity and reinsurance host contracts.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps and option contracts.

Interest Rate Derivatives

The Company purchases interest rate caps to protect against rises in long-term interest rates. The Company utilizes interest rate caps in nonqualifying hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency swaps to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets denominated in foreign currencies.

In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in cash flow and nonqualifying hedging relationships.

Equity Derivatives

The Company uses equity index options to reduce exposure to rising equity markets associated with fixed annuities with equity indexed returns. The Company utilizes equity index options in nonqualifying hedging relationships.

Primary Risks Managed by Derivatives

The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:

		March 31, 2019						December 31, 2018
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In thousands)
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency swaps	Foreign currency exchange rate	$	83,513	$	4,563	$	130	$	82,704	$	5,649	$	187
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate caps	Interest rate	800,000		4,772		—		800,000		9,284		—
Foreign currency swaps	Foreign currency exchange rate	17,892		3,191		96		28,133		3,395		144
Equity index options	Equity market	2,307,473		35,487		9,969		2,154,321		10,389		96
Total non-designated or nonqualifying derivatives		3,125,365		43,450		10,065		2,982,454		23,068		240
Total		$	3,208,878	$	48,013	$	10,195	$	3,065,158	$	28,717	$	427

The following tables present the amount and location of gains (losses) recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):

	Net Derivative Gains (Losses) Recognized for Derivatives (1), (4)			Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)		Net Investment Income (5)		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Three Months Ended March 31, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	—		$	—	$	270	$	(1,035	)
Total cash flow hedges	—			—		270		(1,035		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,512		)	—		—		—
Foreign currency exchange rate derivatives	(36		)	88		—		—
Equity derivatives	36,116			—		—		—
Embedded derivatives	(34,901		)	—		—		—
Total non-qualifying hedges	(3,333		)	88		—		—
Total	$	(3,333	)	$	88	$	270	$	(1,035	)
Three Months Ended March 31, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	6		$	—	$	186	$	(2,674	)
Total cash flow hedges	6			—		186		(2,674		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,002		)	—		—		—
Foreign currency exchange rate derivatives	(972		)	152		—		—
Equity derivatives	(8,736		)	—		—		—
Embedded derivatives	(30,710		)	—		—		—
Total non-qualifying hedges	(44,420		)	152		—		—
Total	$	(44,414	)	$	152	$	186	$	(2,674	)

______________

(1) Includes gains (losses) reclassified from AOCI primarily for terminated cash flow hedges.

(2) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships.

(3) All components of each derivative's gain or loss were included in the assessment of hedge effectiveness.

(4) Total net derivative gains (losses) were ($3.2) million and ($44.3) million for the three months ended March 31, 2019 and 2018 respectively.

(5) Total net investment income was ($452) thousand and ($2.4) million for the three months ended March 31, 2019 and 2018 respectively.

At March 31, 2019 and December 31, 2018, the balance in AOCI associated with foreign currency swaps designated and qualifying as cash flow hedges was $4.8 million and $5.8 million, respectively.

Counterparty Credit Risk

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by International Swaps and Derivatives Association, Inc. (“ISDA”) Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

See Note 6 for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	March 31, 2019						December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In thousands)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	48,331		$	10,160		$	29,006		$	411
Total gross estimated fair value of derivatives (1)	48,331			10,160			29,006			411
Amounts offset on the balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the balance sheets (1)	48,331			10,160			29,006			411
Gross amounts not offset on the balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(3,825		)	(3,825		)	(365		)	(365		)
Cash collateral: (3)
OTC-bilateral	(34,235		)	—			(23,197		)	—
Securities collateral: (4)
OTC-bilateral	(2,875		)	(6,335		)	(2,212		)	(46		)
Net amount after application of master netting agreements and collateral	$	7,396		$	—		$	3,232		$	—

______________

(1) At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $318 thousand and $289 thousand, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($35) thousand and ($16) thousand, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received is included in cash and cash equivalents or in short-term investments, and the obligation to return it is included in payables for collateral transactions on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $2.6 million and $384 thousand, respectively, and did not provide any excess cash collateral, which is not included in the table above due to the foregoing limitation.

(4) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but atMarch 31, 2019,noneof the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. AtMarch 31, 2019andDecember 31, 2018, the Company received excess securities collateral with an estimated fair value of$3.9 millionand$78 thousand, respectively, and provided excess securities collateral with an estimated fair value of$2.3 millionand$112 thousand, respectively, for its OTC-bilateral derivatives.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the counterparty in a net liability position, after considering the effect of netting agreements, to pledge collateral when the amount owed by that counterparty reaches a minimum transfer amount. In addition, the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’sInvestors ServiceandStandard & Poor’s Global Ratings500 Index. If a party’s financial strength or credit ratings were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

At March 31, 2019 and December 31, 2018, the Company held OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements with an estimated fair value of $6.3 million and $46 thousand, respectively. At March 31, 2019 and December 31, 2018, the Company provided collateral with an estimated fair value of $8.7 million and $158 thousand, respectively. The Company’s collateral agreements require both parties to be fully collateralized, as such, the Company would not be required to post additional collateral as a result of a downgrade in its financial strength rating.

Embedded Derivatives

The Company issues certain insurance contracts that contain embedded derivatives that are required to be separated from their host contracts and measured at fair value. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; related party ceded reinsurance of guaranteed minimum benefits related to GMWBs, GMABs and certain GMIBs; and fixed annuities with equity-indexed returns.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	March 31, 2019			December 31, 2018
		(In thousands)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	295,107		$	298,112
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	(33,520	)	$	(18,811	)
Fixed annuities with equity indexed returns	Policyholder account balances	66,887			5,617
Embedded derivatives within liability host contracts		$	33,367		$	(13,194	)

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net derivative gains (losses) (1), (2)	$	(34,901	)	$	(30,710	)

______________

(1) The valuation of direct guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($3.4) millionand($1.1) millionfor thethree months endedMarch 31, 2019, and2018, respectively. In addition, the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were$19.8 millionand($600) thousandfor thethree months endedMarch 31, 2019and2018, respectively.

(2) See Note 10 for discussion of related party net derivative gains (losses).

Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location

The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:

		March 31, 2019						December 31, 2018
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In thousands)
Derivatives Designated as Hedging Instruments:
Cash flow hedges:
Foreign currency swaps	Foreign currency exchange rate	$	83,513	$	4,563	$	130	$	82,704	$	5,649	$	187
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate caps	Interest rate	800,000		4,772		—		800,000		9,284		—
Foreign currency swaps	Foreign currency exchange rate	17,892		3,191		96		28,133		3,395		144
Equity index options	Equity market	2,307,473		35,487		9,969		2,154,321		10,389		96
Total non-designated or nonqualifying derivatives		3,125,365		43,450		10,065		2,982,454		23,068		240
Total		$	3,208,878	$	48,013	$	10,195	$	3,065,158	$	28,717	$	427

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The following tables present the amount and location of gains (losses) recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):

	Net Derivative Gains (Losses) Recognized for Derivatives (1), (4)			Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)		Net Investment Income (5)		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Three Months Ended March 31, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	—		$	—	$	270	$	(1,035	)
Total cash flow hedges	—			—		270		(1,035		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,512		)	—		—		—
Foreign currency exchange rate derivatives	(36		)	88		—		—
Equity derivatives	36,116			—		—		—
Embedded derivatives	(34,901		)	—		—		—
Total non-qualifying hedges	(3,333		)	88		—		—
Total	$	(3,333	)	$	88	$	270	$	(1,035	)
Three Months Ended March 31, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	6		$	—	$	186	$	(2,674	)
Total cash flow hedges	6			—		186		(2,674		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,002		)	—		—		—
Foreign currency exchange rate derivatives	(972		)	152		—		—
Equity derivatives	(8,736		)	—		—		—
Embedded derivatives	(30,710		)	—		—		—
Total non-qualifying hedges	(44,420		)	152		—		—
Total	$	(44,414	)	$	152	$	186	$	(2,674	)

______________

(1) Includes gains (losses) reclassified from AOCI primarily for terminated cash flow hedges.

(2) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships.

(3) All components of each derivative's gain or loss were included in the assessment of hedge effectiveness.

Components of Net Derivatives Gains (Losses)

The following tables present the amount and location of gains (losses) recognized for derivatives and gains (losses) pertaining to hedged items presented in net derivative gains (losses):

	Net Derivative Gains (Losses) Recognized for Derivatives (1), (4)			Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)		Net Investment Income (5)		Amount of Gains (Losses) deferred in AOCI
	(In thousands)
Three Months Ended March 31, 2019
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	—		$	—	$	270	$	(1,035	)
Total cash flow hedges	—			—		270		(1,035		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,512		)	—		—		—
Foreign currency exchange rate derivatives	(36		)	88		—		—
Equity derivatives	36,116			—		—		—
Embedded derivatives	(34,901		)	—		—		—
Total non-qualifying hedges	(3,333		)	88		—		—
Total	$	(3,333	)	$	88	$	270	$	(1,035	)
Three Months Ended March 31, 2018
Derivatives Designated as Hedging Instruments:
Cash flow hedges (3):
Foreign currency exchange rate derivatives	$	6		$	—	$	186	$	(2,674	)
Total cash flow hedges	6			—		186		(2,674		)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives	(4,002		)	—		—		—
Foreign currency exchange rate derivatives	(972		)	152		—		—
Equity derivatives	(8,736		)	—		—		—
Embedded derivatives	(30,710		)	—		—		—
Total non-qualifying hedges	(44,420		)	152		—		—
Total	$	(44,414	)	$	152	$	186	$	(2,674	)

______________

(1) Includes gains (losses) reclassified from AOCI primarily for terminated cash flow hedges.

(2) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships.

(3) All components of each derivative's gain or loss were included in the assessment of hedge effectiveness.

(4) Total net derivative gains (losses) were ($3.2) million and ($44.3) million for the three months ended March 31, 2019 and 2018 respectively.

(5) Total net investment income was ($452) thousand and ($2.4) million for the three months ended March 31, 2019 and 2018 respectively.

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net derivative gains (losses) (1), (2)	$	(34,901	)	$	(30,710	)

______________

(1) The valuation of direct guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($3.4) millionand($1.1) millionfor thethree months endedMarch 31, 2019, and2018, respectively. In addition, the valuation of ceded guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were$19.8 millionand($600) thousandfor thethree months endedMarch 31, 2019and2018, respectively.

(2) See Note 10 for discussion of related party net derivative gains (losses).

Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	March 31, 2019						December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In thousands)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	48,331		$	10,160		$	29,006		$	411
Total gross estimated fair value of derivatives (1)	48,331			10,160			29,006			411
Amounts offset on the balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the balance sheets (1)	48,331			10,160			29,006			411
Gross amounts not offset on the balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(3,825		)	(3,825		)	(365		)	(365		)
Cash collateral: (3)
OTC-bilateral	(34,235		)	—			(23,197		)	—
Securities collateral: (4)
OTC-bilateral	(2,875		)	(6,335		)	(2,212		)	(46		)
Net amount after application of master netting agreements and collateral	$	7,396		$	—		$	3,232		$	—

______________

(1) At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $318 thousand and $289 thousand, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($35) thousand and ($16) thousand, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received is included in cash and cash equivalents or in short-term investments, and the obligation to return it is included in payables for collateral transactions on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $2.6 million and $384 thousand, respectively, and did not provide any excess cash collateral, which is not included in the table above due to the foregoing limitation.

(4) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but atMarch 31, 2019,noneof the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. AtMarch 31, 2019andDecember 31, 2018, the Company received excess securities collateral with an estimated fair value of$3.9 millionand$78 thousand, respectively, and provided excess securities collateral with an estimated fair value of$2.3 millionand$112 thousand, respectively, for its OTC-bilateral derivatives.

Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	March 31, 2019						December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement	Assets			Liabilities			Assets			Liabilities
	(In thousands)
Gross estimated fair value of derivatives:
OTC-bilateral (1)	$	48,331		$	10,160		$	29,006		$	411
Total gross estimated fair value of derivatives (1)	48,331			10,160			29,006			411
Amounts offset on the balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the balance sheets (1)	48,331			10,160			29,006			411
Gross amounts not offset on the balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral	(3,825		)	(3,825		)	(365		)	(365		)
Cash collateral: (3)
OTC-bilateral	(34,235		)	—			(23,197		)	—
Securities collateral: (4)
OTC-bilateral	(2,875		)	(6,335		)	(2,212		)	(46		)
Net amount after application of master netting agreements and collateral	$	7,396		$	—		$	3,232		$	—

______________

(1) At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $318 thousand and $289 thousand, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($35) thousand and ($16) thousand, respectively.

(2) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(3) Cash collateral received is included in cash and cash equivalents or in short-term investments, and the obligation to return it is included in payables for collateral transactions on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $2.6 million and $384 thousand, respectively, and did not provide any excess cash collateral, which is not included in the table above due to the foregoing limitation.

(4) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but atMarch 31, 2019,noneof the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. AtMarch 31, 2019andDecember 31, 2018, the Company received excess securities collateral with an estimated fair value of$3.9 millionand$78 thousand, respectively, and provided excess securities collateral with an estimated fair value of$2.3 millionand$112 thousand, respectively, for its OTC-bilateral derivatives.

Schedule of Derivative Instruments

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	March 31, 2019			December 31, 2018
		(In thousands)
Embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	295,107		$	298,112
Embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances	$	(33,520	)	$	(18,811	)
Fixed annuities with equity indexed returns	Policyholder account balances	66,887			5,617
Embedded derivatives within liability host contracts		$	33,367		$	(13,194	)

XML

Fair Value (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Recurring Fair Value Measurements

	March 31, 2019
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	926,863	$	3,768	$	930,631
U.S. government and agency	391,637		123,719		—		515,356
Foreign corporate	—		363,999		9,957		373,956
CMBS	—		337,733		4,708		342,441
RMBS	—		320,360		—		320,360
ABS	—		77,922		5,469		83,391
State and political subdivision	—		72,093		—		72,093
Foreign government	—		26,636		—		26,636
Total fixed maturity securities	391,637		2,249,325		23,902		2,664,864
Derivative assets: (1)
Interest rate	—		4,772		—		4,772
Foreign currency exchange rate	—		7,754		—		7,754
Equity market	—		35,487		—		35,487
Total derivative assets	—		48,013		—		48,013
Embedded derivatives within asset host contracts (2)	—		—		295,107		295,107
Separate account assets	—		4,559,757		—		4,559,757
Total assets	$	391,637	$	6,857,095	$	319,009	$	7,567,741
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	226	$	—	$	226
Equity market	—		9,969		—		9,969
Total derivative liabilities	—		10,195		—		10,195
Embedded derivatives within liability host contracts (2)	—		—		33,367		33,367
Total liabilities	$	—	$	10,195	$	33,367	$	43,562

	December 31, 2018
	Fair Value Hierarchy
	Level 1		Level 2		Level 3			Total Estimated Fair Value
	(In thousands)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	869,498	$	3,546		$	873,044
U.S. government and agency	389,491		118,028		—			507,519
Foreign corporate	—		342,600		9,764			352,364
CMBS	—		318,120		4,731			322,851
RMBS	—		202,588		—			202,588
ABS	—		78,831		—			78,831
State and political subdivision	—		69,825		—			69,825
Foreign government	—		26,611		—			26,611
Total fixed maturity securities	389,491		2,026,101		18,041			2,433,633
Derivative assets: (1)
Interest rate	—		9,284		—			9,284
Foreign currency exchange rate	—		8,572		472			9,044
Equity market	—		10,389		—			10,389
Total derivative assets	—		28,245		472			28,717
Embedded derivatives within asset host contracts (2)	—		—		298,112			298,112
Separate account assets	—		4,268,423		—			4,268,423
Total assets	$	389,491	$	6,322,769	$	316,625		$	7,028,885
Liabilities
Derivative liabilities: (1)
Foreign currency exchange rate	$	—	$	331	$	—		$	331
Equity market	—		96		—			96
Total derivative liabilities	—		427		—			427
Embedded derivatives within liability host contracts (2)	—		—		(13,194		)	(13,194		)
Total liabilities	$	—	$	427	$	(13,194	)	$	(12,767	)

______________

(1) Derivative assets are presented within other invested assets on the balance sheets and derivative liabilities are presented within other liabilities on the balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the balance sheets.

(2) Embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the balance sheets. Embedded derivatives within liability host contracts are presented within policyholder account balances on the balance sheets.

Fair Value Inputs, Quantitative Information

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					March 31, 2019			December 31, 2018			Impact of Increase in Input on Estimated Fair Value
	Valuation Techniques		Significant Unobservable Inputs		Range			Range
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates	0.02%	-	11.31%	0.02%	-	11%	Decrease (1)
			•	Lapse rates	0.25%	-	16%	0.25%	-	16%	Decrease (2)
			•	Utilization rates	0%	-	25%	0%	-	25%	Increase (3)
			•	Withdrawal rates	0.25%	-	10%	0.25%	-	10%	(4)
			•	Long-term equity volatilities	16.50%	-	22%	16.50%	-	22%	Increase (5)
			•	Nonperformance risk spread	1.31%	-	2.45%	1.91%	-	2.66%	Decrease (6)

______________

(1) Mortality rates vary by age and by demographic characteristics such as gender. Range shown reflects the mortality rate for policyholders between 35 and 90 years old, which represents the majority of the business with living benefits. Mortality rate assumptions are set based on company experience and include an assumption for mortality improvement.

(2) Range reflects base lapse rates for major product categories for duration 1-20, which represents majority of business with living benefit riders. Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies.

(3) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible in a given year. The range shown represents the floor and cap of the GMIB dynamic election rates across varying levels of in-the-money. For lifetime withdrawal guarantee riders, the assumption is that everyone will begin withdrawals once account value reaches zero which is equivalent to a 100% utilization rate. Utilization rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder.

(4) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(5) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(6) Nonperformance risk spread varies by duration. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			Structured Securities			Net Derivatives (2)			Net Embedded Derivatives (3)
	(In thousands)
Three Months Ended March 31, 2019
Balance, beginning of period	$	13,310		$	4,731		$	472		$	311,306
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	2			(32		)	—			(34,901		)
Total realized/unrealized gains (losses) included in AOCI	403			78			—			—
Purchases (6)	—			—			—			—
Sales (6)	(48		)	(29		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(14,665		)
Transfers into Level 3 (7)	263			5,429			—			—
Transfers out of Level 3 (7)	(205		)	—			(472		)	—
Balance, end of period	$	13,725		$	10,177		$	—		$	261,740
Three Months Ended March 31, 2018
Balance, beginning of period	$	95,950		$	19,557		$	—		$	347,633
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	1			109			—			(30,710		)
Total realized/unrealized gains (losses) included in AOCI	(772		)	119			—			—
Purchases (6)	783			1,955			—			—
Sales (6)	(716		)	(403		)	—			—
Issuances (6)	—			—			—			—
Settlements (6)	—			—			—			(5,912		)
Transfers into Level 3 (7)	—			—			—			—
Transfers out of Level 3 (7)	(3,166		)	—			—			—
Balance, end of period	$	92,080		$	21,337		$	—		$	311,011
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2019 (8)	$	4		$	(32	)	$	—		$	13,080
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at March 31, 2018 (8)	$	1		$	109		$	—		$	(33,063	)

______________

(1) Comprised of U.S. and foreign corporate securities.

(2) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(3) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(4) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses). Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

(5) Interest accruals, as well as cash interest coupons received, are excluded from the rollforward.

(6) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(7) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(8) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net embedded derivatives are reported in net derivative gains (losses).

Fair Value of Financial Instruments Carried at Other Than Fair Value

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	March 31, 2019
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	467,193	$	—	$	—	$	472,882	$	472,882
Premiums, reinsurance and other receivables	$	18,415	$	—	$	4,055	$	13,021	$	17,076
Liabilities
Policyholder account balances	$	1,014,394	$	—	$	—	$	938,827	$	938,827
Other liabilities	$	81,790	$	—	$	81,790	$	—	$	81,790

	December 31, 2018
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In thousands)
Assets
Mortgage loans	$	448,105	$	—	$	—	$	447,510	$	447,510
Premiums, reinsurance and other receivables	$	20,001	$	—	$	2,314	$	15,512	$	17,826
Liabilities
Policyholder account balances	$	1,056,419	$	—	$	—	$	949,916	$	949,916
Other liabilities	$	10,399	$	—	$	10,399	$	—	$	10,399

XML

Equity (Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Components of Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI was as follows:

	Three Months Ended   March 31, 2019
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2018	$	(20,503	)	$	5,432		$	(15,071	)
OCI before reclassifications	58,689			(1,035		)	57,654
Deferred income tax benefit (expense)	(12,325		)	217			(12,108		)
AOCI before reclassifications, net of income tax	25,861			4,614			30,475
Amounts reclassified from AOCI	471			—			471
Deferred income tax benefit (expense)	(97		)	—			(97		)
Amounts reclassified from AOCI, net of income tax	374			—			374
Balance, March 31, 2019	$	26,235		$	4,614		$	30,849

	Three Months Ended   March 31, 2018
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Total
	(In thousands)
Balance, December 31, 2017	$	29,323		$	305		$	29,628
OCI before reclassifications	(38,499		)	(2,674		)	(41,173		)
Deferred income tax benefit (expense)	8,083			562			8,645
AOCI before reclassifications, net of income tax	(1,093		)	(1,807		)	(2,900		)
Amounts reclassified from AOCI	2,839			(6		)	2,833
Deferred income tax benefit (expense)	(596		)	1			(595		)
Amounts reclassified from AOCI, net of income tax	2,243			(5		)	2,238
Balance, March 31, 2018	$	1,150		$	(1,812	)	$	(662	)

______________

(1) See Note 4 for information on offsets to investments related to DAC and DSI.

Reclassification out of Accumulated Other Comprehensive Income (Loss)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI						Statements of Operations and Comprehensive Income (Loss) Locations
	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	(465	)	$	(2,839	)	Net investment gains (losses)
Net unrealized investment gains (losses)	(6		)	—			Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	(471		)	(2,839		)
Income tax (expense) benefit	97			596
Net unrealized investment gains (losses), net of income tax	(374		)	(2,243		)
Unrealized gains (losses) on derivatives - cash flow hedges:
Foreign currency swaps	—			6			Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax	—			6
Income tax (expense) benefit	—			(1		)
Gains (losses) on cash flow hedges, net of income tax	—			5
Total reclassifications, net of income tax	$	(374	)	$	(2,238	)

XML

Other Revenues and Other Expenses Other Revenues and Other Expenses (Tables)

3 Months Ended

Mar. 31, 2019

Other Income and Expenses [Abstract]

Schedule of Other Operating Cost and Expense, by Component [Table Text Block]

Information on other expenses was as follows:

	Three Months Ended   March 31,
	2019		2018
	(In thousands)
Compensation	$	4,667	$	3,510
Contracted services and other labor costs	2,596		1,837
Transition services agreements	3,784		2,947
Establishment costs	1,482		—
Premium and other taxes, licenses and fees	704		1,043
Volume related costs, excluding compensation, net of DAC capitalization	3,998		5,264
Other	1,659		1,126
Total other expenses	$	18,890	$	15,727

XML

Related Party Transactions (Tables)

3 Months Ended

Mar. 31, 2019

Related Party Transactions [Abstract]

Effects of reinsurance

Information regarding the significant effects of related party reinsurance included on the interim condensed statements of operations and comprehensive income (loss) was as follows:

	Three Months Ended   March 31,
	2019			2018
	(In thousands)
Premiums
Reinsurance ceded	$	(10,210	)	$	(8,112	)
Universal life and investment-type product policy fees
Reinsurance ceded	$	(803	)	$	(1,043	)
Other revenues
Reinsurance ceded	$	(23,508	)	$	(15,936	)
Policyholder benefits and claims
Reinsurance ceded	$	(8,213	)	$	(24,732	)

Information regarding the significant effects of ceded related party reinsurance included on the interim condensed balance sheets was as follows at:

	March 31, 2019		December 31, 2018
	(In thousands)
Assets
Premiums, reinsurance and other receivables	$	522,891	$	534,487
Liabilities
Other liabilities	$	420,568	$	429,656

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) - segment	3 Months Ended
	Mar. 31, 2019	Aug. 04, 2017
Instrument [Line Items]
Number of segments	2
Spinoff [Member]
Instrument [Line Items]
Common Stock Distribution by Parent		80.80%

XML

Segment Information (Operating Results) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Segment Reporting Information [Line Items]
Pre-tax adjusted earnings	$ (2,755)	$ (19,046)
Provision for income tax expense (benefit)	(1,244)	(4,676)
Net investment gains (losses)	(452)	(2,355)
Net derivative gains (losses)	(3,245)	(44,262)
Other adjustments to net income	(20,323)	(12,544)
Net income (loss)	(1,511)	(14,370)
Annuities
Segment Reporting Information [Line Items]
Interest revenue	17,772	14,803
Life
Segment Reporting Information [Line Items]
Interest revenue	8,304	8,839
Corporate & Other
Segment Reporting Information [Line Items]
Interest revenue	509	371
Operating Segments
Segment Reporting Information [Line Items]
Pre-tax adjusted earnings	(9,788)	15,706
Provision for income tax expense (benefit)	(2,721)	2,621
Adjusted earnings	(7,067)	13,085
Operating Segments | Annuities
Segment Reporting Information [Line Items]
Pre-tax adjusted earnings	(4,979)	5,430
Provision for income tax expense (benefit)	(1,468)	657
Adjusted earnings	(3,511)	4,773
Operating Segments | Life
Segment Reporting Information [Line Items]
Pre-tax adjusted earnings	(4,256)	8,014
Provision for income tax expense (benefit)	(894)	1,683
Adjusted earnings	(3,362)	6,331
Operating Segments | Corporate & Other
Segment Reporting Information [Line Items]
Pre-tax adjusted earnings	(553)	2,262
Provision for income tax expense (benefit)	(359)	281
Adjusted earnings	(194)	1,981
Segment Reconciling Items
Segment Reporting Information [Line Items]
Provision for income tax expense (benefit)	(1,477)	7,297
Net investment gains (losses)	(452)	(2,355)
Net derivative gains (losses)	(3,245)	(44,262)
Other adjustments to net income	$ 10,730	$ 11,865

XML

Segment Information (Reconciliation of Operating Revenues to Total Revenues) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 34,755	$ 1,049
Annuities
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	21,887	27,638
Life
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	12,647	15,696
Corporate & Other
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	670	1,024
Segment Reconciling Items
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ (449)	$ (43,309)

XML

Segment Information (Total Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Total assets	$ 8,757,038	$ 8,130,125
Annuities
Segment Reporting Information [Line Items]
Total assets	7,539,919	7,034,394
Life
Segment Reporting Information [Line Items]
Total assets	1,124,314	1,083,641
Corporate & Other
Segment Reporting Information [Line Items]
Total assets	$ 92,805	$ 12,090

XML

Segment Information (Narrative) (Details)	3 Months Ended
	Mar. 31, 2019 segment
Segment Reporting [Abstract]
Number of segments	2

XML

Insurance (Guarantees Related to Annuity Contracts) (Details) - Variable Annuity Guarantees - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Guaranteed Death Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 4,564,444	$ 4,274,326
Separate account value	4,557,551	4,266,520
Net amount at risk	$ 22,344	$ 193,102
Average attained age of contract holders	68 years	67 years
Guaranteed Annuitization Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 3,703,604	$ 3,483,668
Separate account value	3,702,932	3,482,829
Net amount at risk	$ 211,888	$ 274,632
Average attained age of contract holders	67 years	67 years

XML

Investments (Fixed Maturity Securities AFS by Sector) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	$ 2,623,070	$ 2,469,801
Debt Securities, Available-for-sale	2,664,864	2,433,633
Fixed maturity securities
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	2,623,070	2,469,801
Gross Unrealized Gain	64,917	28,035
Gross Unrealized Temporary Loss	23,123	64,203
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	2,664,864	2,433,633
U.S. corporate
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	916,754	890,676
Gross Unrealized Gain	21,416	5,402
Gross Unrealized Temporary Loss	7,539	23,034
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	930,631	873,044
U.S. government and agency
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	504,101	511,255
Gross Unrealized Gain	15,524	9,961
Gross Unrealized Temporary Loss	4,269	13,697
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	515,356	507,519
Foreign corporate
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	374,509	368,149
Gross Unrealized Gain	6,641	1,473
Gross Unrealized Temporary Loss	7,194	17,258
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	373,956	352,364
CMBS
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	336,322	325,491
Gross Unrealized Gain	7,335	1,481
Gross Unrealized Temporary Loss	1,216	4,121
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	342,441	322,851
RMBS
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	315,454	200,827
Gross Unrealized Gain	6,879	4,643
Gross Unrealized Temporary Loss	1,973	2,882
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	320,360	202,588
ABS
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	83,618	79,806
Gross Unrealized Gain	262	158
Gross Unrealized Temporary Loss	489	1,133
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	83,391	78,831
State and political subdivision
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	65,995	66,131
Gross Unrealized Gain	6,168	4,777
Gross Unrealized Temporary Loss	70	1,083
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	72,093	69,825
Foreign government
Debt Securities, Available for Sale Securities [Abstract]
Amortized Cost	26,317	27,466
Gross Unrealized Gain	692	140
Gross Unrealized Temporary Loss	373	995
Gross Unrealized OTTI Loss	0	0
Debt Securities, Available-for-sale	$ 26,636	$ 26,611

XML

Investments (Maturities of Fixed Maturity Securities) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Available-for-sale Securities, Debt Maturities [Abstract]
Amortized Cost, Due in one Year or less	$ 56,296
Amortized Cost, Due after one year through five years	342,812
Amortized Cost, Due after five years through ten years	898,149
Amortized cost, Due after ten years	590,419
Amortized Cost, Structured Securities	735,394
Amortized Cost, Subtotal	2,623,070	$ 2,469,801
Estimated Fair Value, Due in one year or less	56,866
Estimated Fair Value, Due after one year through five years	344,578
Estimated Fair Value, Due after five years through ten years	906,709
Estimated Fair Value, Due after ten years	610,519
Estimated Fair Value, Structured Securities	746,192
Debt Securities, Available-for-sale	$ 2,664,864	$ 2,433,633

XML

Investments (Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector) (Details) $ in Thousands	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Total number of securities in an unrealized loss position less than 12 months	108	364
Total number of securities in an unrealized loss position equal to or greater than 12 months	181	146
Fixed maturity securities
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	$ 260,316	$ 1,034,440
Less than 12 Months Gross Unrealized Loss	5,641	34,030
Equal to or Greater than 12 Months Estimated Fair Value	713,581	606,708
Equal to or Greater than 12 Months Gross Unrealized Loss	17,482	30,173
U.S. corporate
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	54,218	483,424
Less than 12 Months Gross Unrealized Loss	1,415	15,849
Equal to or Greater than 12 Months Estimated Fair Value	213,094	131,812
Equal to or Greater than 12 Months Gross Unrealized Loss	6,124	7,185
U.S. government and agency
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	0	102,447
Less than 12 Months Gross Unrealized Loss	0	1,925
Equal to or Greater than 12 Months Estimated Fair Value	264,905	296,265
Equal to or Greater than 12 Months Gross Unrealized Loss	4,269	11,772
Foreign corporate
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	68,008	194,924
Less than 12 Months Gross Unrealized Loss	3,251	10,156
Equal to or Greater than 12 Months Estimated Fair Value	102,547	72,803
Equal to or Greater than 12 Months Gross Unrealized Loss	3,943	7,102
CMBS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	8,975	119,412
Less than 12 Months Gross Unrealized Loss	58	1,909
Equal to or Greater than 12 Months Estimated Fair Value	67,525	44,775
Equal to or Greater than 12 Months Gross Unrealized Loss	1,158	2,212
RMBS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	72,806	57,510
Less than 12 Months Gross Unrealized Loss	130	1,746
Equal to or Greater than 12 Months Estimated Fair Value	46,591	28,573
Equal to or Greater than 12 Months Gross Unrealized Loss	1,843	1,136
ABS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	39,489	51,028
Less than 12 Months Gross Unrealized Loss	389	985
Equal to or Greater than 12 Months Estimated Fair Value	11,104	11,699
Equal to or Greater than 12 Months Gross Unrealized Loss	100	148
State and political subdivision
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	6,175	18,260
Less than 12 Months Gross Unrealized Loss	25	744
Equal to or Greater than 12 Months Estimated Fair Value	7,815	13,999
Equal to or Greater than 12 Months Gross Unrealized Loss	45	339
Foreign government
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	10,645	7,435
Less than 12 Months Gross Unrealized Loss	373	716
Equal to or Greater than 12 Months Estimated Fair Value	0	6,782
Equal to or Greater than 12 Months Gross Unrealized Loss	$ 0	$ 279

XML

Investments (Mortgage Loans by Portfolio Segment) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Loans and Leases Receivable Disclosure [Line Items]
Carrying value	$ 469,199	$ 450,042
Mortgage loans, gross as a percentage of total mortgage loans, net	100.40%	100.40%
Mortgage loans valuation allowances	$ (2,006)	$ (1,937)
Mortgage loans valuation allowances as a percentage of total mortgage loans, net	(0.40%)	(0.40%)
Total mortgage loans, net	$ 467,193	$ 448,105
Total mortgage loans, net as a percentage of total mortgage loans, net	100.00%	100.00%
Mortgage Loans | Commercial
Loans and Leases Receivable Disclosure [Line Items]
Carrying value	$ 319,650	$ 310,681
Mortgage loans, gross as a percentage of total mortgage loans, net	68.40%	69.30%
Mortgage Loans | Agricultural
Loans and Leases Receivable Disclosure [Line Items]
Carrying value	$ 149,549	$ 139,361
Mortgage loans, gross as a percentage of total mortgage loans, net	32.00%	31.10%

XML

Investments (Credit Quality of Commercial Mortgage Loans) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	$ 469,199	$ 450,042
% of Total	100.00%	100.00%
Less than 65%
Financing Receivable, Recorded Investment [Line Items]
% of Total	92.70%	94.00%
65% to 75%
Financing Receivable, Recorded Investment [Line Items]
% of Total	6.00%	4.60%
76% to 80%
Financing Receivable, Recorded Investment [Line Items]
% of Total	1.30%	1.40%
Mortgage Loans | Commercial
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	$ 319,650	$ 310,681
Mortgage Loans | Commercial | Less than 65%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	296,122	292,128
Mortgage Loans | Commercial | 65% to 75%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	19,240	14,257
Mortgage Loans | Commercial | 76% to 80%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	4,288	4,296
Mortgage Loans | Commercial | Greater than 1.20x
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	301,202	292,234
Mortgage Loans | Commercial | Greater than 1.20x | Less than 65%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	277,674	273,681
Mortgage Loans | Commercial | Greater than 1.20x | 65% to 75%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	19,240	14,257
Mortgage Loans | Commercial | Greater than 1.20x | 76% to 80%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	4,288	4,296
Mortgage Loans | Commercial | 1.00x - 1.20x
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	5,000	5,000
Mortgage Loans | Commercial | 1.00x - 1.20x | Less than 65%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	5,000	5,000
Mortgage Loans | Commercial | 1.00x - 1.20x | 65% to 75%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	0	0
Mortgage Loans | Commercial | 1.00x - 1.20x | 76% to 80%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	0	0
Mortgage Loans | Commercial | Less than 1.00x
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	13,448	13,447
Mortgage Loans | Commercial | Less than 1.00x | Less than 65%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	13,448	13,447
Mortgage Loans | Commercial | Less than 1.00x | 65% to 75%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	0	0
Mortgage Loans | Commercial | Less than 1.00x | 76% to 80%
Financing Receivable, Recorded Investment [Line Items]
Recorded investment	$ 0	$ 0

XML

Investments (Credit Quality of Agricultural Mortgage Loans) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Financing Receivable, Allowance for Credit Losses [Line items]
Recorded investment	$ 469,199	$ 450,042
% of Total	100.00%	100.00%
Less than 65%
Financing Receivable, Allowance for Credit Losses [Line items]
% of Total	94.80%	96.10%
65% to 75%
Financing Receivable, Allowance for Credit Losses [Line items]
% of Total	5.20%	3.90%
Mortgage Loans | Agricultural
Financing Receivable, Allowance for Credit Losses [Line items]
Recorded investment	$ 149,549	$ 139,361
Mortgage Loans | Agricultural | Less than 65%
Financing Receivable, Allowance for Credit Losses [Line items]
Recorded investment	141,731	133,884
Mortgage Loans | Agricultural | 65% to 75%
Financing Receivable, Allowance for Credit Losses [Line items]
Recorded investment	$ 7,818	$ 5,477

XML

Investments (Net Unrealized Investment Gains (Losses)) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Components of net unrealized investment gains (losses) included in accumulated other comprehensive loss
Fixed maturity securities	$ 41,793	$ (36,166)
Derivatives	4,756	5,791
Subtotal	46,549	(30,375)
DAC and DSI	(7,500)	11,299
Deferred income tax benefit (expense)	(8,200)	4,005
Net unrealized investment gains (losses)	$ 30,849	$ (15,071)

XML

Investments (Changes in Net Unrealized Investment Gains (Losses)) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Changes In Net Unrealized Investment Gains Losses Included In Accumulated Other Comprehensive Loss [Abstract]
Balance, December 31, 2018	$ (15,071)
Unrealized investment gains (losses) during the period	76,924
Unrealized investment gains (losses) relating to:
DAC and DSI	(18,799)
Deferred income tax benefit (expense)	(12,205)
Balance, March 31, 2019	30,849
Change in net unrealized investment gains (losses)	$ 45,920

XML

Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Invested assets on deposit (regulatory deposits)	$ 1,530	$ 1,482
Invested assets pledged as collateral (1)	8,652	158
Total invested assets on deposit and pledged as collateral (2)	$ 10,182	$ 1,640

XML

Investments (Variable Interest Entities) (Details) - Fixed maturity securities - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Variable Interest Entity [Line Items]
Carrying Amount	$ 489,002	$ 409,699
Maximum Exposure to Loss	$ 480,919	$ 409,699

XML

Investments (Net Investment Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net Investment Income [Line Items]
Less: Investment expenses	$ 1,056	$ 879
Net investment income	26,493	23,931
Fixed maturity securities
Net Investment Income [Line Items]
Gross Investment Income, Operating	22,913	20,365
Mortgage loans
Net Investment Income [Line Items]
Gross Investment Income, Operating	3,899	4,191
Cash, cash equivalents and short-term investments
Net Investment Income [Line Items]
Gross Investment Income, Operating	387	158
Other
Net Investment Income [Line Items]
Gross Investment Income, Operating	350	96
Subtotal
Net Investment Income [Line Items]
Gross Investment Income, Operating	$ 27,549	$ 24,810

XML

Investments (Components of Net Investment Gains (Losses)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Marketable Securities, Gain (Loss) [Abstract]
Fixed maturity securities	$ (468)	$ (2,839)
Other net investment gains (losses):
Mortgage loans	(69)	(82)
Other	85	566
Total net investment gains (losses)	$ (452)	$ (2,355)

XML

Investments (Sales or Disposals of Fixed Maturity Securities) (Details) - Debt Securities [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Components of Sales or Disposals of Fixed Maturity and Equity Securities
Proceeds	$ 55,477	$ 53,561
Gross investment gains	150	15
Gross investment losses	(618)	(2,854)
Total OTTI losses recognized in earnings:
Net investment gains (losses)	$ (468)	$ (2,839)

XML

Investments (Fixed Maturity Securities AFS - Narrative) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Summary of Certain Fixed Maturity Securities [Abstract]
Debt Securities, Available-for-sale	$ 2,664,864	$ 2,433,633
Non-Income Producing Debt Securities
Summary of Certain Fixed Maturity Securities [Abstract]
Debt Securities, Available-for-sale	0	0
Gross Unrealized Gain Loss	$ 0	$ 0

XML

Investments (Continuous Gross Unrealized Losses for Fixed Maturity Securities AFS by Sector - Narrative) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) Contracts
Debt Securities, Available-for-sale [Line Items]
Fixed maturity securities available-for-sale with gross unrealized loss of equal to or greater than stated percentage	20.00%
Fixed maturity securities
Debt Securities, Available-for-sale [Line Items]
Change in Gross Unrealized Termporary Loss	$ (41,100)
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	23,100
20% or more | Six months or greater | Fixed maturity securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ 940
Number of Securities | Contracts	1

XML

Investments (Mortgage Loans - Narrative) (Details)	3 Months Ended			12 Months Ended
	Mar. 31, 2019 Contracts	Mar. 31, 2019 Contracts	Mar. 31, 2018 Contracts	Dec. 31, 2018 Contracts
Financing Receivable, Recorded Investment, Aging [Abstract]
Percentage of mortgage loans classified as performing	100.00%	100.00%		100.00%
Number of mortgage loans modified in troubled debt restructuring	0	0	0	0
Commercial
Financing Receivable, Recorded Investment, Aging [Abstract]
Number of loans past due	0	0		0
Recorded investment of loans in nonaccrual status	0	0		0
Agricultural
Financing Receivable, Recorded Investment, Aging [Abstract]
Number of loans past due	0	0		0
Recorded investment of loans in nonaccrual status	0	0		0

XML

Investments (Cash Equivalents - Narrative) (Details) - USD ($) $ in Millions	Mar. 31, 2019	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Cash equivalents	$ 0.0	$ 89.9

XML

Investments (Concentrations of Credit Risk - Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Investments in any counterparty that were greater than 10% of equity	$ 0	$ 0
Securities holdings exposure in single issuer greater than stated percentage of Company's equity	10.00%

XML

Investments (Variable Interest Entities - Narrative) (Details) $ in Thousands	Dec. 31, 2018 USD ($)
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net [Abstract]
Variable interest, consoldidated carrying amount assets and liabilities net	$ 0

XML

Investments (Net Investment Income & Net Investment Gains (Losses) - Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Gains (losses) from foreign currency transactions	$ 10	$ 414

XML

Investments (Related Party Investment Transactions - Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Related Party Transaction [Line Items]
Related party investment administrative services	$ 15,100	$ 9,700
Metlife Investment Advisors, LLC
Related Party Transaction [Line Items]
Related party investment administrative services	$ 0	$ 766

XML

Derivatives (Primary Risks Managed by Derivatives) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Gross Notional Amount	$ 3,208,878	$ 3,065,158
Derivative Asset, Fair Value, Gross Asset	48,013	28,717
Derivative Liability, Fair Value, Gross Liability	10,195	427
Derivatives Designated as Hedging Instruments: | Cash flow hedges: | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	83,513	82,704
Derivative Asset, Fair Value, Gross Asset	4,563	5,649
Derivative Liability, Fair Value, Gross Liability	130	187
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivatives, Fair Value [Line Items]
Gross Notional Amount	3,125,365	2,982,454
Derivative Asset, Fair Value, Gross Asset	43,450	23,068
Derivative Liability, Fair Value, Gross Liability	10,065	240
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate caps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	800,000	800,000
Derivative Asset, Fair Value, Gross Asset	4,772	9,284
Derivative Liability, Fair Value, Gross Liability	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Equity index options
Derivatives, Fair Value [Line Items]
Gross Notional Amount	2,307,473	2,154,321
Derivative Asset, Fair Value, Gross Asset	35,487	10,389
Derivative Liability, Fair Value, Gross Liability	9,969	96
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	17,892	28,133
Derivative Asset, Fair Value, Gross Asset	3,191	3,395
Derivative Liability, Fair Value, Gross Liability	$ 96	$ 144

XML

Derivatives Derivatives (NQ, CF, FV) Details (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	$ 88	$ 152
Amount of Gains (Losses) deferred in AOCI	(1,035)	(2,674)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	88	152
Amount of Gains (Losses) deferred in AOCI	0	0
Cash flow hedges (3):
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	0	0
Amount of Gains (Losses) deferred in AOCI	(1,035)	(2,674)
Net Derivative Gains (Losses) Recognized for Derivatives (1), (4)
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	(3,333)	(44,414)
Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	(3,333)	(44,420)
Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Cash flow hedges (3):
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	0	6
Net Investment Income (5)
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	270	186
Net Investment Income (5) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	0	0
Net Investment Income (5) | Cash flow hedges (3):
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	270	186
Interest rate derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	0	0
Amount of Gains (Losses) deferred in AOCI	0	0
Interest rate derivatives | Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	(4,512)	(4,002)
Interest rate derivatives | Net Investment Income (5) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	0	0
Foreign currency exchange rate derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	88	152
Amount of Gains (Losses) deferred in AOCI	0	0
Foreign currency exchange rate derivatives | Cash flow hedges (3):
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	0	0
Amount of Gains (Losses) deferred in AOCI	(1,035)	(2,674)
Foreign currency exchange rate derivatives | Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	(36)	(972)
Foreign currency exchange rate derivatives | Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Cash flow hedges (3):
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	0	6
Foreign currency exchange rate derivatives | Net Investment Income (5) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	0	0
Foreign currency exchange rate derivatives | Net Investment Income (5) | Cash flow hedges (3):
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	270	186
Equity derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	0	0
Amount of Gains (Losses) deferred in AOCI	0	0
Equity derivatives | Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	36,116	(8,736)
Equity derivatives | Net Investment Income (5) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	0	0
Embedded derivatives | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Net Derivative Gains (Losses) Recognized for Hedged Items (2), (4)	0	0
Amount of Gains (Losses) deferred in AOCI	0	0
Embedded derivatives | Net Derivative Gains (Losses) Recognized for Derivatives (1), (4) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	(34,901)	(30,710)
Embedded derivatives | Net Investment Income (5) | Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivative Instruments, Gain (Loss) [Line items]
Derivative, Gain (Losses) on Derivative, Net	$ 0	$ 0

XML

Derivatives (Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset Excluding Accruals	$ 48,331	$ 29,006
Derivative Liability, Fair Value, Gross Liability Excluding Accruals	10,160	411
Amounts offset in the consoilidated balance sheets, Assets	0	0
Amounts offset in the consoilidated balance sheets, Liabilities	0	0
Estimated fair value of derivative assets presented in the consolidated balance sheets	48,331	29,006
Estimated fair value of derivative liabilities presented in the consolidated balance sheets	10,160	411
Net amount of derivative assets after application of master netting agreements and cash collateral	7,396	3,232
Net amount of derivative liabilities after application of master netting agreements and cash collateral	0	0
OTC-bilateral (1)
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset Excluding Accruals	48,331	29,006
Derivative Liability, Fair Value, Gross Liability Excluding Accruals	10,160	411
Gross estimated fair value of derivative assets	(3,825)	(365)
Gross estimated fair value of derivative liabilities	(3,825)	(365)
Cash collateral on derivative assets	(34,235)	(23,197)
Cash collateral on derivative liabilities	0	0
Securities collateral on derivative assets	(2,875)	(2,212)
Securities collateral on derivative liabilities	$ (6,335)	$ (46)

XML

Derivatives (Embedded Derivatives) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded derivatives within liability host contracts	$ 33,367		$ (13,194)
Premiums, reinsurance and other receivables | Ceded guaranteed minimum benefits
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded derivatives within asset host contracts	295,107		298,112
Policyholder account balances | Direct guaranteed minimum benefits
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded derivatives within liability host contracts	(33,520)		(18,811)
Policyholder account balances | Fixed Annuity
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Embedded derivatives within liability host contracts	66,887		$ 5,617
Net Derivative Gain (Loss)
Derivatives, Fair Value [Line Items]
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	$ (34,901)	$ (30,710)

XML

Derivatives (NQ, FV, CF - Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gain (Loss) on Derivative Instruments, Net, Pretax	$ (3,245)	$ (44,262)
Net investment gains (losses)	(452)	$ (2,355)
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	$ 4,800		$ 5,800

XML

Derivatives (Credit Risk on Freestanding Derivatives - Narrative) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Credit Derivatives [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 48,013	$ 28,717
Derivative Liability, Fair Value, Gross Liability	10,195	427
Derivative, Collateral, Obligation to Return Cash	2,600	384
Customer Securities for which Entity has Right to Sell or Repledge, Fair Value of Securities Sold or Repledged	0
Estimated Fair Value of Derivatives in Net Liability Position	6,300	46
Accrued Liabilities
Credit Derivatives [Line Items]
Derivative Asset, Fair Value, Gross Asset	318	289
Derivative Liability, Fair Value, Gross Liability	0	(16)
Fixed Maturities
Credit Derivatives [Line Items]
Collateral Already Posted, Aggregate Fair Value	8,700	158
Over the Counter
Credit Derivatives [Line Items]
Derivative, Collateral, Obligation to Return Securities	3,900	78
Derivative, Collateral, Right to Reclaim Securities	$ 2,300	$ 112

XML

Derivatives (Embedded Derivatives - Narrative) (Details) - Nonperformance Risk - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Direct And Assumed Guaranteed Minimum Benefit
Embedded Derivative [Line Items]
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	$ (3,400)	$ (1,100)
Ceded guaranteed minimum benefits
Embedded Derivative [Line Items]
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	$ 19,800	$ (600)

XML

Fair Value (Recurring Fair Value Measurements) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets [Abstract]
Debt Securities, Available-for-sale	$ 2,664,864	$ 2,433,633
Derivative assets	48,013	28,717
Separate account assets	4,559,757	4,268,423
Liabilities [Abstract]
Derivative liabilities	10,195	427
Embedded derivatives within liability host contracts	33,367	(13,194)
Recurring
Assets [Abstract]
Debt Securities, Available-for-sale	2,664,864	2,433,633
Derivative assets	48,013	28,717
Embedded derivatives within asset host contracts	295,107	298,112
Separate account assets	4,559,757	4,268,423
Total assets	7,567,741	7,028,885
Liabilities [Abstract]
Derivative liabilities	10,195	427
Embedded derivatives within liability host contracts	33,367	(13,194)
Total liabilities	43,562	(12,767)
Recurring | Interest rate derivatives
Assets [Abstract]
Derivative assets	4,772	9,284
Recurring | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	7,754	9,044
Liabilities [Abstract]
Derivative liabilities	226	331
Recurring | Equity derivatives
Assets [Abstract]
Derivative assets	35,487	10,389
Liabilities [Abstract]
Derivative liabilities	9,969	96
Recurring | U.S. corporate
Assets [Abstract]
Debt Securities, Available-for-sale	930,631	873,044
Recurring | U.S. government and agency
Assets [Abstract]
Debt Securities, Available-for-sale	515,356	507,519
Recurring | Foreign corporate
Assets [Abstract]
Debt Securities, Available-for-sale	373,956	352,364
Recurring | CMBS
Assets [Abstract]
Debt Securities, Available-for-sale	342,441	322,851
Recurring | RMBS
Assets [Abstract]
Debt Securities, Available-for-sale	320,360	202,588
Recurring | ABS
Assets [Abstract]
Debt Securities, Available-for-sale	83,391	78,831
Recurring | State and political subdivision
Assets [Abstract]
Debt Securities, Available-for-sale	72,093	69,825
Recurring | Foreign government
Assets [Abstract]
Debt Securities, Available-for-sale	26,636	26,611
Recurring | Level 1
Assets [Abstract]
Debt Securities, Available-for-sale	391,637	389,491
Derivative assets	0	0
Embedded derivatives within asset host contracts	0	0
Separate account assets	0	0
Total assets	391,637	389,491
Liabilities [Abstract]
Derivative liabilities	0	0
Embedded derivatives within liability host contracts	0	0
Total liabilities	0	0
Recurring | Level 1 | Interest rate derivatives
Assets [Abstract]
Derivative assets	0	0
Recurring | Level 1 | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 1 | Equity derivatives
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 1 | U.S. corporate
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 1 | U.S. government and agency
Assets [Abstract]
Debt Securities, Available-for-sale	391,637	389,491
Recurring | Level 1 | Foreign corporate
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 1 | CMBS
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 1 | RMBS
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 1 | ABS
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 1 | State and political subdivision
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 1 | Foreign government
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 2
Assets [Abstract]
Debt Securities, Available-for-sale	2,249,325	2,026,101
Derivative assets	48,013	28,245
Embedded derivatives within asset host contracts	0	0
Separate account assets	4,559,757	4,268,423
Total assets	6,857,095	6,322,769
Liabilities [Abstract]
Derivative liabilities	10,195	427
Embedded derivatives within liability host contracts	0	0
Total liabilities	10,195	427
Recurring | Level 2 | Interest rate derivatives
Assets [Abstract]
Derivative assets	4,772	9,284
Recurring | Level 2 | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	7,754	8,572
Liabilities [Abstract]
Derivative liabilities	226	331
Recurring | Level 2 | Equity derivatives
Assets [Abstract]
Derivative assets	35,487	10,389
Liabilities [Abstract]
Derivative liabilities	9,969	96
Recurring | Level 2 | U.S. corporate
Assets [Abstract]
Debt Securities, Available-for-sale	926,863	869,498
Recurring | Level 2 | U.S. government and agency
Assets [Abstract]
Debt Securities, Available-for-sale	123,719	118,028
Recurring | Level 2 | Foreign corporate
Assets [Abstract]
Debt Securities, Available-for-sale	363,999	342,600
Recurring | Level 2 | CMBS
Assets [Abstract]
Debt Securities, Available-for-sale	337,733	318,120
Recurring | Level 2 | RMBS
Assets [Abstract]
Debt Securities, Available-for-sale	320,360	202,588
Recurring | Level 2 | ABS
Assets [Abstract]
Debt Securities, Available-for-sale	77,922	78,831
Recurring | Level 2 | State and political subdivision
Assets [Abstract]
Debt Securities, Available-for-sale	72,093	69,825
Recurring | Level 2 | Foreign government
Assets [Abstract]
Debt Securities, Available-for-sale	26,636	26,611
Recurring | Level 3
Assets [Abstract]
Debt Securities, Available-for-sale	23,902	18,041
Derivative assets	0	472
Embedded derivatives within asset host contracts	295,107	298,112
Separate account assets	0	0
Total assets	319,009	316,625
Liabilities [Abstract]
Derivative liabilities	0	0
Embedded derivatives within liability host contracts	33,367	(13,194)
Total liabilities	33,367	(13,194)
Recurring | Level 3 | Interest rate derivatives
Assets [Abstract]
Derivative assets	0	0
Recurring | Level 3 | Foreign currency exchange rate
Assets [Abstract]
Derivative assets	0	472
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 3 | Equity derivatives
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 3 | U.S. corporate
Assets [Abstract]
Debt Securities, Available-for-sale	3,768	3,546
Recurring | Level 3 | U.S. government and agency
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 3 | Foreign corporate
Assets [Abstract]
Debt Securities, Available-for-sale	9,957	9,764
Recurring | Level 3 | CMBS
Assets [Abstract]
Debt Securities, Available-for-sale	4,708	4,731
Recurring | Level 3 | RMBS
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 3 | ABS
Assets [Abstract]
Debt Securities, Available-for-sale	5,469	0
Recurring | Level 3 | State and political subdivision
Assets [Abstract]
Debt Securities, Available-for-sale	0	0
Recurring | Level 3 | Foreign government
Assets [Abstract]
Debt Securities, Available-for-sale	$ 0	$ 0

XML

Fair Value (Assets and Liabilities Measured - Quantitative Information) (Details) - Level 3	Mar. 31, 2019	Dec. 31, 2018
Measurement Input, Mortality Rate | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.0002	0.0002
Measurement Input, Mortality Rate | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.1131	0.1100
Measurement Input, Lapse Rate | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.0025	0.0025
Measurement Input, Lapse Rate | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.1600	0.1600
Measurement Input, Utilization Rate | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.0000	0.0000
Measurement Input, Utilization Rate | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.2500	0.2500
Measurement Input, Withdrawal Rate | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.0025	0.0025
Measurement Input, Withdrawal Rate | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.1000	0.1000
Measurement Input, Long Term Equity Volatilities | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.1650	0.1650
Measurement Input, Long Term Equity Volatilities | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.2200	0.2200
Measurement Input, Entity Credit Risk | Minimum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.0131	0.0191
Measurement Input, Entity Credit Risk | Maximum
Fair Value, Option, Quantitative Disclosures [Line Items]
Embedded Derivative Liability, Measurement Input	0.0245	0.0266

XML

Fair Value (Unobservable Input Reconciliation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
NetDerivatives [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance, beginning of period	$ 472	$ 0
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	0	0
Total realized/unrealized gains (losses) included in AOCI	0	0
Purchases (6)	0	0
Sales (6)	0	0
Issuances (6)	0	0
Settlements (6)	0	0
Transfers into Level 3 (7)	0	0
Transfers out of Level 3 (7)	(472)	0
Balance, end of period	0	0
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0
Net Embedded Derivatives (3)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance, beginning of period	311,306	347,633
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	(34,901)	(30,710)
Total realized/unrealized gains (losses) included in AOCI	0	0
Purchases (6)	0	0
Sales (6)	0	0
Issuances (6)	0	0
Settlements (6)	(14,665)	(5,912)
Transfers into Level 3 (7)	0	0
Transfers out of Level 3 (7)	0	0
Balance, end of period	261,740	311,011
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	13,080	(33,063)
Corporate (1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	13,310	95,950
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	2	1
Total realized/unrealized gains (losses) included in AOCI	403	(772)
Purchases (6)	0	783
Sales (6)	(48)	(716)
Issuances (6)	0	0
Settlements (6)	0	0
Transfers into Level 3 (7)	263	0
Transfers out of Level 3 (7)	(205)	(3,166)
Balance, end of period	13,725	92,080
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	4	1
Structured Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	4,731	19,557
Total realized/unrealized gains (losses) included in net income (loss) (4) (5)	(32)	109
Total realized/unrealized gains (losses) included in AOCI	78	119
Purchases (6)	0	1,955
Sales (6)	(29)	(403)
Issuances (6)	0	0
Settlements (6)	0	0
Transfers into Level 3 (7)	5,429	0
Transfers out of Level 3 (7)	0	0
Balance, end of period	10,177	21,337
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	$ (32)	$ 109

XML

Fair Value (Financial Instruments Carried at Other Than Fair Value) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Carrying Value
Assets
Mortgage loans	$ 467,193	$ 448,105
Premiums, reinsurance and other receivables	18,415	20,001
Liabilities
Policyholder account balances	1,014,394	1,056,419
Other liabilities	81,790	10,399
Estimate of Fair Value Measurement
Assets
Mortgage loans	472,882	447,510
Premiums, reinsurance and other receivables	17,076	17,826
Liabilities
Policyholder account balances	938,827	949,916
Other liabilities	81,790	10,399
Estimate of Fair Value Measurement | Level 1
Assets
Mortgage loans	0	0
Premiums, reinsurance and other receivables	0	0
Liabilities
Policyholder account balances	0	0
Other liabilities	0	0
Estimate of Fair Value Measurement | Level 2
Assets
Mortgage loans	0	0
Premiums, reinsurance and other receivables	4,055	2,314
Liabilities
Policyholder account balances	0	0
Other liabilities	81,790	10,399
Estimate of Fair Value Measurement | Level 3
Assets
Mortgage loans	472,882	447,510
Premiums, reinsurance and other receivables	13,021	15,512
Liabilities
Policyholder account balances	938,827	949,916
Other liabilities	$ 0	$ 0

XML

Equity (Capital Transactions) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Equity [Abstract]
Capital contribution	$ 75,000	$ 0

XML

Equity (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	$ (15,071)	$ 29,628
OCI before reclassifications	57,654	(41,173)
Deferred income tax benefit (expense)	(12,108)	8,645
AOCI before reclassifications, net of income tax	30,475	(2,900)
Amounts reclassified from AOCI	471	2,833
Deferred income tax benefit (expense)	(97)	(595)
Amounts reclassified from AOCI, net of income tax	374	2,238
Balance, end of period	30,849	(662)
Unrealized Investment Gains (Losses), Net of Related Offsets (1)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	(20,503)	29,323
OCI before reclassifications	58,689	(38,499)
Deferred income tax benefit (expense)	(12,325)	8,083
AOCI before reclassifications, net of income tax	25,861	(1,093)
Amounts reclassified from AOCI	471	2,839
Deferred income tax benefit (expense)	(97)	(596)
Amounts reclassified from AOCI, net of income tax	374	2,243
Balance, end of period	26,235	1,150
Unrealized Gains (Losses) on Derivatives
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	5,432	305
OCI before reclassifications	(1,035)	(2,674)
Deferred income tax benefit (expense)	217	562
AOCI before reclassifications, net of income tax	4,614	(1,807)
Amounts reclassified from AOCI	0	(6)
Deferred income tax benefit (expense)	0	1
Amounts reclassified from AOCI, net of income tax	0	(5)
Balance, end of period	$ 4,614	$ (1,812)

XML

Equity (Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Investments	$ (452)	$ (2,355)
Net derivative gains (losses)	(3,245)	(44,262)
Net unrealized investment gains (losses), before income tax	(2,755)	(19,046)
Income tax (expense) benefit	1,244	4,676
Net income (loss)	(1,511)	(14,370)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	(374)	(2,238)
Reclassification out of Accumulated Other Comprehensive Income | Net unrealized investment gains (losses):
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gain (Loss) on Investments	(465)	(2,839)
Net derivative gains (losses)	(6)	0
Net unrealized investment gains (losses), before income tax	(471)	(2,839)
Income tax (expense) benefit	97	596
Net income (loss)	(374)	(2,243)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized gains (losses) on derivatives - cash flow hedges:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net unrealized investment gains (losses), before income tax	0	6
Income tax (expense) benefit	0	(1)
Net income (loss)	0	5
Reclassification out of Accumulated Other Comprehensive Income | Unrealized gains (losses) on derivatives - cash flow hedges: | Foreign currency swaps
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net derivative gains (losses)	$ 0	$ 6

XML

Other Expenses (Other Expenses) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Other Income and Expenses [Abstract]
Compensation	$ 4,667	$ 3,510
Contracted services and other labor costs	2,596	1,837
Transition services agreements	3,784	2,947
Establishment costs	1,482	0
Premium and other taxes, licenses and fees	704	1,043
Volume related costs, excluding compensation, net of DAC capitalization	3,998	5,264
Other	1,659	1,126
Total other expenses	$ 18,890	$ 15,727

XML

Other Revenues and Other Expenses Other Revenues (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Distribution Service [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 3.1	$ 3.5

XML

Contingencies, Commitments and Guarantees (Commitments and Guarantees - Narrative) (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Liabilities for indemnities, guarantees and commitments	$ 0	$ 0
Mortgage Loan Commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	21,800,000	7,600,000
Commitments to Fund Private Corporate Bond Investments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	$ 3,500,000	$ 11,400,000

XML

Related Party Transactions (Effects of Affiliated Reinsurance on Statements of Operations) (Details) - Affiliated Entity - Ceded - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Premiums
Reinsurance ceded	$ (10,210)	$ (8,112)
Universal life and investment-type product policy fees
Reinsurance ceded	(803)	(1,043)
Other revenues
Reinsurance ceded	(23,508)	(15,936)
Policyholder benefits and claims
Reinsurance ceded	$ (8,213)	$ (24,732)

XML

Related Party Transactions (Effects of Affiliated Reinsurance on Balance Sheets) (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets:
Premiums, reinsurance and other receivables	$ 574,277	$ 580,480
Liabilities:
Other liabilities	538,759	471,490
Ceded | Affiliated Entity
Assets:
Premiums, reinsurance and other receivables	522,891	534,487
Liabilities:
Other liabilities	$ 420,568	$ 429,656

XML

Related Party Transactions (Reinsurance Transactions - Narrative) (Details) - Affiliated Entity - Ceded guaranteed minimum benefits - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Embedded Derivative, Fair Value of Embedded Derivative Asset	$ 295.1		$ 298.1
Net derivatives gains (losses)	$ (3.5)	$ (45.8)

XML

Related Party Transactions Related Party Transactions (Shared Services and Overhead Allocations - Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party	$ 15,100,000	$ 9,700,000
Insurance Commissions and Fees	23,250,000	25,986,000
Costs and Expenses, Related Party	(260,000)	0
All Services and Transactions Except Broker Dealer Activities [Member]
Related Party Transaction, Due from (to) Related Party	(941,000)		$ 622,000
Affiliated Entity
Insurance Commissions and Fees	$ 2,900,000	$ 3,200,000

XML

Related Party Transactions Related Party Transactions (Broker Dealer Transactions - Narrative) (Details) - Broker Dealer Activities [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Revenue from Related Parties	$ 2,800	$ 3,200
Related Party Transaction, Expenses from Transactions with Related Party	14,700	$ 13,100
Due from Related Parties	$ 993		$ 951